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GENERAL INTRODUCTION 
Dissertation Organization 
This dissertation is composed of two separate manuscripts. Each manuscript is 
complete in itself. The Ph.D. candidate. Young S. Lyoo, is the senior author and 
principal investigator for both manuscripts. The first manuscript describes expression of 
recombinant proteins VP2, VP4. VP6 and VP7 of bovine rotavirus, in a baculovtrus 
system and preliminary characterization of the recombinant proteins. Rotavirus specific 
recombinant proteins were detected by immunoassays using polyclonal antiserum to the 
VMRI strain of bovine rotavirus. Kinetics of protein expression and characteristics of 
recombinant proteins were determined by radioimmunoprecipitation. Antigenicity of 
recombinant proteins was determined by inoculation of guinea pigs and the immune 
response of guinea pigs was evaluated by indirect immunofluorescence and virus 
neutralization tests. 
The second manuscript reports on the effect of removal of terminal noncoding 
sequences on expression of VP7 in a baculovirus expression system. Removal of both 
the 3' end and 5' end noncoding sequences upstream and downstream of the open 
reading frame increased VP7 expression. 
In addition, a General Introduction and a current review of the literature related to 
this research work is included before the manuscripts, as well as a General Conclusion 
section. Literature Cited section listing references cited in the General Introduction and 
literature Review, and Acknowledgment section, after the manuscripts. 
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Introduction 
Rotaviruses are a common cause of gastroenteritis in neonates of animals and 
man (Flewett and Woode. 1978; Estes et al., 1983; Paul and Stevenson, 1992; Paul and 
Lyoo, 1993). They were first isolated in the U.S. from calves with diarrhea by Mebus et 
al., (1969), and now have been identified in most animal species of veterinary 
imporunce including catde, swine, sheep, horses, dogs. cats, chickens and turkeys 
(Flewett and Woode, 1978; Estes etal., 1983; Estes and Cohen, 1989: Paul and 
Stevenson, 1992, Paul and Lyoo, 1993). Rotavirus infection in humans was first 
described in 1973 by electron microscopy of samples isolated from the duodenum, 
detecting the infectious agent of acute gastro-intestinal infection of hospitalized young 
children (Bishop et al., 1973). Infections with rotavirus are common in most of tiiese 
species and often may be subclinical. Virus strain, dosage, environmental factors, and 
involvement of other secondary pathogens influence the severity of disease and the 
outcome of infection. Rotaviruses infect the small intestine via fecal-oral route, and the 
rapidity of spread is aided by inhalation after aerosol formation (Sattar and Ijaz. 1987). 
Rotaviruses survive well in the environment and thus provide an ample opportunity of 
exposure to susceptible host animals. Rotavirus survival on contaminated human hands, 
environmental surfaces (Ansari et al., 1988), tap water (Sattar et al., 1984a, b), sewage 
(Hejkal et al., 1984), and virus resistance to chemical disinfectants (Sattar et al., 1983) 
are well understood. 
Protection of neonates against rotaviruses is complicated by extensive antigenic 
variability among rotaviruses, and resistance to environmental factors. Seven 
antigenically distinct groups (A-G) have been identified which further contain serotypes. 
Within the group A rotaviruses, which were the first to be identified and are the best 
characterized, are large number of serotypes based on the two surface proteins VP4 and 
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VF7. The VP4 and VP7 of group A rotaviruses, are important in serotype determinadon 
and in inducing neutralizing antibodies and protective immunity (Dyall-Smith et al., 
1986; Hoshino et al., 1985,1988; Hardy et al., 1992). Multiple serotypes of group A 
rotaviruses based on glycoprotein VP7 (designated as G t5rpes) and based on VP4 (P 
types) have been identified. There are at least 14 G types and 12 P types identified so far 
and this trend will possibly continue in the future. Groups B and C rotaviruses, which 
have recently been characterized, have been shown to possess VP4 and VP7 equivalents 
(Chen et al., 1990; Bremont et al., 1992; Qian et al., 1991). The induction of immunity 
is further complicated by the fact that circulating antibodies may not provide solid 
protection against rotavirus infection. Antibodies, preferably IgA, need to bathe the 
villus epithelium of the gastrointestinal tract for them to be protective against rotavirus 
infection. Therefore, the most successful approaches in inducing protective immunity 
have utilized the stimulation of lactogenic immunity in dams so that the antibodies in milk 
protect the intestinal tract of the suckling animals from rotaviral infection. Active 
immunity, especially mucosal immunity, protects older animals from re-exposure to 
rotavirus infection of a homologous serotype. Vaccines are commercially available for 
rotavirus infections in catde and pigs. In addition, genetic reassortant viruses have been 
tested as potential vaccine candidates. Current development of recombinant protein 
expression technology allowed us to characterize the recombinant rotavirus proteins 
expressed in baculovirus. 
Our hypothesis was that recombinant proteins expressed in baculovirus would be 
authentic viral proteins as in rotavirus and they would induce neutralization antibodies to 
rotavirus. Our belief in part was based on studies showing that the recombinant proteins 
expressed in baculovirus are similar to native proteins because the insect cell system 
mimics similar machinery of protein processing to that of mammalian cells. Because one 
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of the major neutralization proteins, VP7, is a glycosylated protein, the choice of this 
eukaryotic expression system has an advantage over the prokaryotic expression system in 
post translarional modification of recombinant protein. We also expected the recombinant 
proteins of VP4 and VP7 would retain their ability to induce neutralizing antibodies in 
experimental animals. Expression of VP2 and VP6 provided an opportunity to 
investigate the assembly of virus-like particles. 
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LITERATURE REVIEW 
The History of Rotavirus 
It has been 25 years since rotavirus was recognized as a causative agent of 
gastroenteritis in calves and now rotavirus has been isolated from a variety of species of 
animals and in humans. Extensive information is available on pathogenesis, modes of 
virus transmission, diagnosis of rotaviral infection, and molecular genetics of rotavirus. 
However, rotavirus infection still remains an important health problem in animals and in 
humans. Vaccines are available in a few species, however their effectiveness is limited. 
Mechanisms of mucosal immunity to rotavirus and other enteric pathogens needs better 
clarification. Even though rotavirus immunogens have been identified (Paul and Lyoo, 
1993) their role in protection against calf diarrhea is poorly understood. Serotypic 
diversity further complicates prevention and control of rotavirus associated 
gastroenteritis. 
Rotavirus was first isolated from calves with diarrhea by Mebus et al. (1969), 
and subsequendy this virus was identified in most animal species (Table 1) of veterinary 
importance including cattle, pigs, sheep, horses, dogs, cats, chickens and turkeys 
(Flewett and Woode, 1978; Estes et al., 1983; Snodgrass et al., 1984; Estes and Cohen. 
1989: Paul and Stevenson, 1992). Rotavirus infection in human was first described in 
1973 by electron microscopy of intestinal contents of hospitalized young children with 
acute gastro-intestinal infection (Bishop et al., 1973). 
Rotaviruses 
Rotaviruses belong to the genus rotavirus under the family Reoviridae . The 
name is derived from the Latin word rota (wheel) which illustrates the appearance of 
virus particles by electron microscopy. Rotavirus particles are nonenveloped, are 
Table I. Known sero^jroups and RNA elecDophoretic patterns of rotaviruses affecting animals and human. 
Serogroiip Elcclnipliorelic Palleni 
of RNA scunicnis 
Animal Spccies Affeclcd Refeiunces 
A 4:2:3:2 Caltlc (NCDV), 
Pigs, Sheep, Foals, Dogs, 
Cats; Rabbits; Man 
Mcbiis ct al., 1969; Sec review by Flcwett and W(X)dc, 1978; Estes el 
al., 1983; Paul & Stevenson, 1992 
5:1:3:2 Avian Todd et al., 1980 
B 4:2:2:3 
Pigs 
Caltlc 
Man 
Pedley el at., 1983; Theil el at., 1985 
Snodgrass el al., 1984 
Chen el al., 1985 
C 4:3:2:2 
Pigs 
Calllc 
Man 
Saif CI al., 1980; Bohl el al., 1982 
T.suneiniisii el al„ 1991 
Rodger el at., 1982 
D 5:2:2:2 Chicken McNully et al., 1981; McNully el al., 1984; Bridger, 1987; 
Snodgrass et al., 1984 
E 4:2:2:3 Pigs Pedley el al., 1986 
F 4:3:2:2 Chickens and Turkeys McNully el al, 1984; Bridger, 1987 
G 4:2:2:3 Chickcns McNully el al, 1984; Bridger. 1987 
o\ 
* Adapted from Paul and Lyoo (1994) 
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triple-layered and measure approximately 75 nm in diameter by electron microscopic 
examination. Recent evidence based on high resolution cryoelectron microscopy (Prasad 
et al., 1988, 1990; Anthony et al., 1991) suggest that rotaviral particles have 60 surface 
spikes about 10 nm long with a globular end structure. Rotaviral particles with surface 
spikes measure approximately 100 nm in diameter. The single capsid viral particles 
measure 60 nm and the core particles are 52 nm in diameter. Viral cores contain the viral 
transcriptase and a genome consisting of 11 segments of double stranded RN.A.. Each 
RNA segment starts with a 5' guanidine followed by highly conserved sequences that are 
part of the 5' non-translational sequences, an open reading frame coding for each protein, 
another set of 3' non-coding sequences and finally a 3'-terminal cytosine (Estes and 
Cohen, 1989). 
Only triple-layered particles are infectious in susceptible animals and cell cultures. 
The virus enters into susceptible cells by direct cell membrane penetration, not by 
endocytosis (Kaljot et al., 1988). But there is controversy regarding the proteins 
involved in target cell binding and cell entry. The VP4. VP7 and NS35 are believed to 
possess target cell binding proteins (Sahara et al., 1985; Bass et al., 1990, 1991). 
Only the triple-layered (previously called double-shelled) viral particles are 
infectious (Zeng et al.. 1994). Rotaviruses are difficult to adapt for growth in cell 
cultures with conventional virus isolation methods in the presence of serum as a 
supplement. They require pretreatment with proteolytic enzymes such as trypsin and 
pancreatin (Theil and Bohl, 1980; Terrett and Saif, 1987). Cell lines commonly used for 
rotavirus propagation include the monkey kidney cell line MA-104 and CV-1, the human 
liver cell line HepG2, and the human colon ceU line CaCo-2 (Kitamoto et al., 1991). 
Rotaviruses are classified into antigenically distinct serogroups by 
immunofluorescence, immune electron microscopy, or enzyme linked immunosorbent 
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assay (ELISA). Seven serogroups have been established. Rotaviruses within a 
serogroup, regardless of species of origin, share a conimon group antigen. The 
electrophoredc patterns of rotaviruses belonging to separate groups are also distinctive 
and can tentatively be used to classify rotaviruses. The genomic EINA segments cluster 
into four regions I to IV. Mammalian group A rotaviruses have a 4:2:3:2 pattern in 
regions 1,11, HI, and IV. Avian group A rotavirus has a 5:1:3:2 pattern. This pattern is 
4:2:2:3 in group B and E mammalian rotaviruses, 4:3:2:2 in group C rotavirus and 
5:2:2:2 in avian group D rotaviruses (McNulty et al.. 1981). Species from which these 
rotaviruses have thus far been isolated is shown in Table 1. Rotaviruses within 
serogroup A are further divided into subgroups and serotypes. Two subgroups, I and II, 
are well established. There is evidence that there may be additional serogroups of 
rotaviruses which lack these subgroup antigens. Serotyping of rotaviruses is 
cumbersome and sometimes confusing as the two surface proteins, VP4 and VP7, both 
contribute to virus neutralization and serotype specificity. The VP4 in older literature 
was referred to as VP3 until a new name was proposed by Liu et al. (1988). The genes 
coding for these two proteins segregate independently and classical virus neutralization 
tests using hyperinunune antisera to rotavirus primarily determine VP7 types. A new 
classification has been proposed (Estes and Cohen. 1989) which takes into account both 
surface proteins. Rotavirus types based on VP4 have been designated as P types, 
whereas types based on VP7 have been referred to as G types. Monoclonal antibodies 
and nucleic acid probes have been successfully used to differentiate rotavirus G and P 
types (Johnson et al., 1990; Zaberezhny et al., 1991). A summary of rotaviruses with 
the major G and P types detected in animals is presented in Table 3. 
Limited data are available as to the predominant species of rotaviruses prevalent in 
diarrheic neonates of most species. In cattie, rotaviruses with G6 are most common and 
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two additional serotypes designated serotypes 8 and 10 have been reported (Taniguchi et 
al, 1991b: Luetal., 1994). Snodgrass et al. (1990) using MAb-based serotype-specific 
ELISA found that 66% of 162 samples were of G6 serotype. 1% were GIO and the 
others were untypable. Using Northern blot hybridization or dot blot hybridization, 
rotaviruses with P5 and 06 were the most common in diarrheic calves (Brooks et al.. 
1989; Mummidi et al.. 1992). One report indicates that serotype 1 (T449) is also present 
in bovine (Blackball et al., 1992) but significance of this serotype in gastroenteritis and 
its relative prevalence in cattle is not known. Recent data indicates that rotaviruses with 
additional O and P types may be present in calves (Mummidi et al., 1992). In horses, 
the 03 serotype is most predominant (Browning et al., 1992: Hardy et al., 1991). Out 
of 70 equine rotavirus isolates tested 63% were serotype 03. 4% were 013, and 33% 
were untypable (Browning et al., 1992). Hardy et al. (1991) found aU of the isolates 
they analyzed were of 03 serotype. In pigs, rotaviruses with 04 and 05 predominate 
(Zaberezhny et al., 1991; Pauletal., 1992a). 
Oroup A rotaviruses are the best characterized group of rotaviruses. There are at 
least 11 proteins coded in rotavirions (Estes and Cohen, 1989), sLx of which are major 
structural proteins which are VP 1, VP2, VP3, VP4, VP6, and VP7 (Table 2). Among 
these proteins, VP6 is the most abundant protein making up 51% of the virion, forms the 
inner capsid and is required for viral transcription. AU viruses within a serogroup share 
this antigen regardless of species of origin. The major group and subgroup antigens are 
encoded in the VP6 protein. VPl is a viral polymerase and resides in the subcore of the 
virion. This protein is slighdy basic and has a ODD motif which is important for EINA 
dependent EINA polymerase activity (Mattion et al., 1994). VP2 has a nucleic acid 
binding activity and is present in the core with a portion of it sticking through the inner 
capsid. VP2 and VP6 contribute to subgroup specificity. VP3 is encoded by gene 
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segment 3 and is present in core particles as a subcore protein with approximately 0.5% 
of virion weight. The protein is basic and possesses guanyltransferase activity. VP4 is a 
spike protein which possesses neutralization and fusion activities (Mattion et al.. 1994). 
VP7 is heavily glycosylated and possesses neutralization activity (Table 3). More 
detailed information on the characteristics of VP2, VP4, VP6, and VP7 follow in order to 
provide better understanding of this dissertation. 
VP2 
The VP2 is encoded by gene segment 2 (2690 bp) of rotavirus. It is the most 
abundant protein found in rotavirus core particles, and is the third abundant viral protein 
in triple-layered particles. The core of the virion is formed predominandy by this VP2. 
which forms the innermost layer and surrounds the viral genome, VPl and VP3. 
Rotavirus particles contain 200 molecules of VP2 (Mattion et al., 1994) which are 
partially exposed on single shelled particles. This protein is highly immunogenic and 
serum antibodies to VP2 are an evidence of prior infection. The VP2 protein is rich in 
proline (>3.6%) and most of the proline residues are conserved among various serotypes 
of rotaviruses. There are two perfect heptad repeats of leucine present in the RF strain of 
bovine rotavirus (aa 536-557 and aa 665-6X6) and simian rotavirus strain S A11 (aa 538-
560, and aa 667-689) which are suggestive of leucine zipper (Labbe et al., 1994; Mattion 
et al., 1994). It was hypothesized that these two motifs are important in protein-nucleic 
acid interaction. The VP2 is a structural protein which has been shown to possess nucleic 
acid binding activity with a preference for ssRNA over dsRNA. Its binding activity is 
not sequence dependenL 
II 
Table 2. Genome size and selected characteristics of group A rotavirus*. 
Segment 
Number 
of base pairs 
Length of 
noncoding sequence** 
5'end 3'end Protein products 
1 
L 3302 18 17 VPl 
2 2690 16 28 VP2 
3 2591 49 34 VP3 
4 2362 9 22 VP4 
5 1611 30 93 NSPl*** 
6 1356 23 139 VP6 
7 1104 25 131 NSP3 
8 1059 46 59 NSP2 
9 1062 48 33 VP7 
10 751 41 182 NSP4 
11 667 20 49 NSP5 
Adapted from Matrion et al., (1994) for group A simian rotavirus SAl I 
** Number of 5' noncoding sequences is up to the first AUG start codon; number of 3' 
noncoding sequences does not include the termination codon. 
*** Nomenclature for non-structural proteins CNSP) is adapted from recent papers 
(Mattion et al., 1994). 
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Table 3. Structural proteins of group A rotavirus and their characteristics* 
Protein 
Nascent polypeptide 
molecular mass 
(number amino acids) 
Mature protein 
modified 
No. of 
molecules Location and 
per virion(% w/v)** Function 
VPl 125 lcDa(1088) (2) Subcore protein 
GDD motif, pol­
ymerase activity 
VP2 102.4 kDa (880) Mjaistolylated 200(15) Core protein. 
RNA binding 
Leucine zipper 
VP3 98.1 kDa (835) (0.5) Subcore protein 
guanyltransferase 
VP4 86.7 kDa (776) Cleaved 120 (1.5) Spike protein, 
dimer, HA, P-
type antigen, 
attachment 
protein, 
virulence 
VP6 44.8 kDa (397) Myristolylated 780 (51) Subgroup antigen 
trimer, inner 
capsid protein 
VP7 37.3 kDa (326) Glycosylation 780 (30) Neutralization 
antigen, surface 
glycoprotein. G-
type antigen,. 
Ca"*^ binding 
* Adapted from Mattion et al. (1994) based on data generated for simian group A 
rotavirus strain SAl 1 
** % by weight of virion protein 
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VP4 
The VP4 is a minor surface protein comprising 1.5% of the virion. Based on 
cryoelectron microscopy, VP4 is present in a dimeric form making up 60 surface spikes 
(Pra.sad et al.. 1988). It is nonglycosylated and is a hemagglutinin in many virus strains. 
It has many important biological functions, e.g. virulence, restriction of virus growth in 
cell cultures, virus neutralization, and hemagglutination (Estes and Cohen, 1989). The 
VP4 is very important in homotypic protection as well as heterotypic immunity' (Paul and 
Lyoo, 1993). The VP4 is coded in gene segment 4 (2362 bp) has 776 amino acid 
residues and is sensitive to cleavage by proteolytic enzymes. Trypsin cleaves VP4 at 
arginine residue 241 or 247 resulting in two fragments: VP5 and VPS. The VPS 
fragment is 247 amino acids in length and represents approximately the amino-terminal 
one-third portion of VP4. Five type-specific sites are located in VPS, with a majority of 
these located in the hypervariable region between amino acids 71 and 204 (Larralde and 
Gorziglia, 1992). The VP5 fragment is 529 amino acids long and has 3 major 
neutralization epitopes. Epitope I is a linear epitope located at amino acid residue 306. 
epitope n is a conformational epitope located at amino acid residues 392 and 439 and 
epitope in is located at amino acid residue 434 (Taniguchi et al, 19S9). A cross reactive 
epitope has been localized at amino acid residue 393. Also VP4 is the primary 
immunogen that stimulates neutralization antibodies following natural infection with 
rotavirus (Ward et al., 1988). Immunization of mice widi recombinant VP4 produced in 
a baculovirus expression system induced a high level of neutralizing antibodies to the 
homologous serotype as well as a low level of a cross reactive neutralization response to 
heterologous serotypes (Mackow et al., 1990). Heterotypic neutralization epitopes have 
been located on VP5, the carboxy terminal protein of VP4 after cleavage with a 
proteolytic enzyme such as trypsin. Neutralization epitopes of VP4 have been mapped 
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using synthetic peptides (Arias et al.. 1989"). Amino acid residues 232-255 emulsified 
with keyhole limpet hemocyanin as an immunological carrier produced neutralizing 
antibodies to VP4. This synthetic peptide also provided protection equal to that obtained 
with whole bovine rotavirus immunization (Arias et al., 1989). 
VP6 
The VP6 is encoded by genome segment 6 (1362 bp) and is the major viral 
structural protein in the virus particles comprising 51% of virion. The protein is located 
on the double layered particles with trimeric structure. The intermediate layer of rotavirus 
particles are formed by this protein. High resolution electron cryomicroscopy has shown 
that VP6 is composed of 260 trimeric columns and is stabilized by noncovalent bonds 
(Prasad et al.. 1988., Yeager et al., 1990). A proportion of the VP6 protein in the virion 
is about 60% in triple-layered particles with a high percentage of predicted (3 strucoires 
and a low percentage of a helix. VP6 is myristoylated, despite the absence of amino-
terminal sequences which are associated with N-myristoylation and is rich in proline 
(5.2%) (Clark and Desselberger, 1988). VP6 is the primary antigen used in most of the 
diagnostic tests. Serologically, subgroup antigens have been found in VP6 which have 
served as epidemiological tools as subgroup 1 has primarily been associated with human 
rotavirus strains and subgroup II with animal rotavirus strains. The role of VP6 in 
protection from rotavirus associated gastroenteritis is not clear however, partial protection 
in offspring of mice immunized with recombinant VP6 has been reported (Redmond et 
al., 1993). 
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VP7 
VP7 is the major neutralization glycoprotein which plays an important role in 
serotype specific virus neutralization (Greenberg et al., 1983a). The outer capsid of the 
virion is made up of 780 molecules of VP7 (Prasad et al., 1988). The VP7 is coded in 
gene segment 7, 8 or 9 depending upon the virus strain. VP7 gene is 1062 bases long 
and the number of amino acid residues coded by the open reading frame is 326. .After 
cleavage of the signal peptide, the mature cleaved protein contains 276 amino acids. The 
VP7 is glycosylated with high concentration of mannose. is the major surface protein and 
comprises 30% of the virion. It has a molecular mass of 37 kDa. The VP7 is the major 
neutralization antigen of the rotavirus and it is believed to function as a cell attachment 
protein (Estes and Cohen, 1989; Mattion et al, 1994). Nucleotide sequence analysis has 
identified sLx regions on VP7 which are highly conserved among different strains of the 
same serotype but are divergent among different serotypes (Glass et al., 1985; Green et 
al., 1987). Three of these regions encode for neutralization epitopes A, B and C as 
shown by studies using escape mutants. Region A is located at amino acid residues 87-
101, region B at amino acid residues 145-152, and region C is located at amino acid 
residues 211-223 (Dyall-Smith et al., 1986). Regions A and C are located in close 
proximity after protein folding and region C appears to be the most immunodominant 
antigenic site on VP7. The recombinant VP7 protein and syndietic peptide (275-295) of 
VP7 has been shown to induce neutralizing antibodies as well as protection in animals 
against rotavirus infection (Arias et al, 1986; Francavilla et al, 1987; Bishop, 1993; 
Dormitzer et al, 1994). 
Viral proteins involved in virus neutralization of group A rotaviruses are protease 
sensitive protein VP4 and glycoprotein VP7. These two proteins are also important for 
virus classification and serotyping of group A rotaviruses. VP4 and VP7 equivalents 
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have also been identified in groups B and C rotaviruses by nucleotide sequence analysis 
(Chen et al., 1990: Bremont et al., 1992: Qian et al., 1991). Surface proteins VP4 and 
VP7 are the major immunogens of rotavirus (Paul and Lyoo. 1993). Both VP4 and VP7 
have been shown to elicit neutralization antibodies to rotavirus. Studies on reassortant 
vu^ses containing either the VP4 or VP7 genes of the parent virus and other genes from 
an unrelated serotype demonstrated that the neutralization specificities of these genes 
segregate independendy (Hoshino et al., 1985: Offit et al 1986). Hyperimmune 
monospecific antisera to VP4 and VP7 neutralized rotavirus (Bastardo et al., 1981). 
Additionally, monoclonal antibodies to these proteins have been shown to neutralize 
rotavirus and the neutralizing monoclonal antibodies to VP4 and VP7 have been shown 
to be protective against rotavirus infections (Greenberg et al.. 1983a, 1983b: Sahara et 
al.. 1985: Matsuietal., 1989). 
Immunity to Rotavirus Infections 
Animals develop an active immunity to rotavirus infection following natural or 
experimental exposure. Immunity is usually serotype specific (Murakami et al., 1986: 
Snodgrass et al., 1991), however, a low level of heterotypic immunity may also be 
observed (Woode et al.. 1987). Humoral, mucosal and cellular immunity have been 
demonstrated in natural host and experimental animal models following infection (Hung 
et al, 1985: Dharakul et al, 1991). Mucosal immunity is of prime imponance in 
protection against rotavirus infections as protection is usually correlated with the presence 
of antibodies in secretions (Woode et al., 1983). Neutralizing antibodies in the intestinal 
tract have been correlated with protection from infection wi± rotavirus. Secretory IgA is 
more effective in protection than IgG and IgM because IgA is more resistant to 
proteolytic degradation in the intestinal tract due to a carbohydrate-rich secretory 
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component and is tiie predominant immunoglobulin in secretions, including milk, in most 
animal species (Grimwood et al, 1988). Mucosal immunity is generally best induced by 
oral immunization and circulating antibodies are usually not protective (Offit and Clark, 
1985). 
Immunity in neonates may also be passively acquired through colostrum and/or 
milk. This has been referred to as lactogenic immunity and is the only viable approach in 
protection of animals during early life. Again, IgA is the predominant immunoglobulin 
in milk and is most efficientiy induced by oral immunization. In cattie, the major 
immunoglobulin in milk is IgGl whose concentration increases in milk following 
maternal immunization. Efficacy of passive immunity has also been demonstrated by 
feeding dairy calves colostrum firom cows vaccinated with rotavirus (Acres et al., 1978; 
Snodgrass et al., 1982a, 1982b; Tsunemitsu et al., 1989). This data indicates that 
vaccination of pregnant cow results in high level of antibodies in colostrum. Susceptible 
calves fed antibody enriched colostrum are protected from rotavirus associated 
gastroenteritis. 
Cellular immunity has also been shown to play an imponant role in viral 
clearance. Offit and Dudzik (1989) demonstrated cytotoxic T cell activity in mice 7 days 
after rotavirus infection. This cellular cytotoxic activity was specific for rotavirus and 
was the major histocompatibility complex-restricted. The CD8"^ T lymphocytes have 
also been shown to play an important role in virus clearance in a severe combined 
immunodeficiency (SCID) mice model (Dharakul et al., 1990). SCID mice inoculated 
early in life with a murine rotavirus strain EDIM (Epidemic Diarrhea in Infant Mice) 
became persistendy infected (Riepenhoff-Talty et al, 1987) and chronically shed vims 
without overt clinical signs of gastroenteritis. Transfer of splenic cells or intraepithelial 
lymphocytes transientiy eliminated chronic virus shedding demonstrating the role of T 
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lymphocytes in rotavirus clearance. Natural killer cell activity has also been 
demonstrated for chicken intraepithelial lymphocytes against target cells infected with 
chicken rotavirus (Myers and Schat, 1990). 
The immune response to specific rotavirus proteins is generally proportional to 
their concentration on the rotavirion, but is influenced by the assay used. By 
conventional ELISA, the majority of the immune response detected is directed to the 
major structural protein VP6 and therefore ELISA results do not correspond to resistance 
of animals to rotavirus infection. Rotavirus specific IgA levels correspond with 
resistance to rotavirus infection. There may be a correlation between protection and 
neutralization antibody titers. In one study, neutralization titers of 1:128 to a 
homologous virus correlated with resistance in infants to the same serotype, whereas, 
lower titers were not protective (Chiba et al., 1986). The neutralizing antibodies are 
directed to the surface proteins VP4 and VP7 and can be measured by epitope blocking 
assays using VP4 and VP7 specific neutralizing monoclonal antibodies. The immune 
response is mainly homotypically directed to the type specific epitopes on both VP4 and 
VP7 after primary infection, and is against both type and cross reactive epitopes on the 
two surface proteins after secondary infection or multiple immunizations (Snodgrass et 
al., lyyI). The immune response to different.subunits of VP4 has also been investigated 
in infants vaccinated with rhesus rotavirus. It was found that the immune response to 
VP4 correlated with responses detected by a plaque reduction test and that the VP8 
subunit was more immunogenic than the VPS subunit of VP4 (Padilla-Noriega et al., 
1992). 
Tremendous effort has been made to develop an effective vaccine to prevent 
rotavirus gastroenteritis in animals and humans. Development of an effective vaccine is a 
high priority in controlling rotavirus gastroenteritis in reducing economic losses and in 
19 
keeping children healthy (Kapikian et al.. 1989: Daum et al., 1991). Rotavirus vaccines 
are currently commercially available for cattle and pigs and are expected to be available 
for other species in the near future. In cattle, a modified live virus vaccine is 
commercially available but does not provide complete protection. There are two possible 
explanations for limited efficacy of currentiy available vaccines. Serotype diversity 
possibly plays a role for the limited protection in that the vaccine virus strain does not 
induce protective immunity against heterologous strains. The other possible reason is 
that the amount of immunogens in vaccine preparation might not be sufficient to induce 
protective immunity. 
Current trends and approaches in developing an effective rotavirus vaccine are 
diverse. Reassortant rotaviruses with a VP4 from one serotj^e and VP7 from a different 
rotavirus serotype have shown to protect against a challenge with both parent viruses 
(Hoshino et al.. 1985, 1988). Hoshino et al. (1988) produced a reassortant rotavirus 11-
l (P7: G4) which contained the VF7 gene from the Gottfried strain (P6: 04) and the VP7 
and other genes from the OSU strain (P7:05). Oral administration to gnotobiotic pigs 
with the reassonant rotavirus 11-1 induced high levels of neutralizing antibody titers for 
both OSU and Gottfried and also protected the pigs from infection with both parent virus 
strains. Similar experiments have been conducted in a mouse model (Offit et al., 1986) 
in which reassortant rotavirus S-4 containing gene 4 from simian rotavirus SAl 1 and the 
rest of the genes from bovine rotavirus NCDV induced neutralization antibodies for both 
SA-11 and NCDV. In addition to dual neutralization antibody production, mice 
immunized with this reassortant virus were protected against rotavirus gastroenteritis 
from both parent rotavirus strains. These studies suggest that heterogeneity among 
rotaviruses can in part be overcome by employing reassortant rotaviruses encompassing 
the spectrum of rotavirus serotypes prevalent in a particular animal species. They also 
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could be useful in making vaccines against strains that grow poorly in cell cultures by 
incorporating the VP7 genes from such strains in cell culture adapted rotaviruses. 
Animal rotavirus strains such as a bovine strain WC3 and rhesus rotavirus strain 
RRV have been tested for vaccines in infants (Clark et al.. 1986: Berstein et al.. 1990). 
This approach has been termed the Jennerian approach and has some potential in 
development of a vaccine for the prevention of rotavirus gastroenteritis (Kapikian, 1994). 
The recombinant approach is also being explored for vaccine development 
Rotaviral proteins have been expressed using prokaryotic and eukaryotic expression 
vectors with varying results (Francavilla et al., 1987; Sahara et al., 1991). VP7 
expressed in vaccinia virus and recombinant vaccinia virus containing SAl 1 rotavirus 
VP7 induced serotype specific neutralizing antibodies in rabbits (Andrew et al.. 1987). 
In contrast VP7 expressed in E. coli was not consistent in inducing vims neutralization 
antibodies (Arias et al., 1986; Francavilla et al., 1987). VP4 has also been successfully 
expressed in baculovirus (Nishikawa et al., 1989; Mackow et al., 1989) and the 
recombinant VP4 protein similar to that of the parent virus, reacted with monoclonal 
antibodies directed to major neutralization epitopes, and induced neutralizing antibodies 
in mice (Nishikawa et al, 1989; Mackow et al., 1990). 
Baculovirus as an Expression Vector 
Recent biotechnological developments in virology have provided a better 
understanding of the viral genome structure and characterization of the function(s) of 
proteins including their role in immunity and protection. The baculovirus expression 
system has been quite useful. Baculoviruses are commonly found in insects and 'baculo' 
refers to the rod-shaped capsids of the viral particles. Viral replication occurs in the 
nucleus of the infected insect cell. An extracellular form of the virus is produced early in 
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infection by migration of the progeny virus from the nucleus to the cytoplasm and buds 
out of the cell membrane into the cellular surface. This mechanism results in cell-to-cell 
spread as well as secondary infection in the organism. During late infection, viral 
particles are embedded in a protein crystal (polyhedrin). Such crystals have been referred 
to as occlusions. The genome of the Autographa California nuclear polyhedrosis virus 
(AcMNPV) is approximately 130 Kb and is a covalently closed double stranded DNA 
molecule with a superhelical configuration (O'Reilly et al.. 1992). The helper 
independent baculovirus is one of the most popular eukaryotic expression systems. It is 
unique from bacterial and yeast systems in that foreign genes are expressed under the 
transcriptional control of the very strong baculovirus polyhedrin gene promoter and 
recombinant proteins are produced in insect cells during lytic infection with a DNA viral 
vector (O'Reilly et al.. 1992; Luckowand Summers, 1988a, 1989; Maeda, 1989). 
Recendy, a variety of expression vectors have been developed and used to express 
foreign genes (Luckow and Summers, 1988b). This system has been used to express 
many viral, mammalian, plant and prokaryodc genes with relatively abundant amounts in 
a functionally authentic form (see Table 4). Genomic DMAs containing genes without 
introns or cDNA clones are presentiy recommended for expression in baculovirus. A 
number of factors affect the level of protein expression. Removal of the 5' non-
translated DNA sequence is also recommended for optimal expression of a foreign gene 
(Luckow and Summers, 1988a). Insect cell lines also differ in the amount of protein 
expression and Trichoplusia /z/,-derived BTI-TN-5B1-4 (Hi-Five) was one of the very 
efficient cell lines for a high level of protein expression (Davis et al., 1993). The 
baculovirus expression system allows virus-like particle assembly when the proper 
combination of viral protein(s) is expressed in insect cells. Norwalk virus, rotavirus, 
rabbit hemorrhagic disease virus and parvovirus were able to produce virus-like particle 
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formation in the baculovirus expression system (Jiang et al., 1992; Labbe et al.. 1991: 
Laurent et al., 1994). Recombinant proteins expressed in the baculovirus system are 
listed in Table 4. 
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Table 4. Recombinant proteins expressed in the bacuiovinis system and their selected 
characteristics. 
Recombinant protein Cellular location Protein modification Reference 
Alkaline phosphatase 
Bovine eye protein 
Rhodopsin receptor 
Membrane Glycosylated Janssen et al.. 1988 
CD4 (T4) 
(hydrophilic 
extracellular element) 
Secreted Glycosylated Hussey et al., 1988 
Dengue envelope 
glycoprotein (E) 
Plasma membrane Glycosylated Zhang et al., 1988 
Dengue NS1 Glycosylated Zhang etal., 1988 
Endogenous human 
gastrin-releasing 
peptide precursor 
Secreted Lebacq-Verheyden et 
al., 1988 
Hepatitis B virus 
surface antigen 
Lumen. RER Glycosylated Lanford et al., 1988 
Hepatitis B virus 
surface antigen 
Secreted Glycosylated Kang et al.. 1987 
Hepatitis B virus 
M protein 
Secreted Price etal., 1988 
HIV gpI60 Cell surface Glycosylated Rusch et al., 1987 
Human alpha 
interferon 
Secreted Maedaetal., 1984 
Human beta 
interferon 
Secreted 
Glycosylated 
Signal peptide Smith etal., 1983 
Influenza virus 
haemagglutinin 
Integral membrane 
protein 
acylated/oligomeric 
assembly/ 
glycosylated 
Kurodaetal., 1986 
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Table 4. (Continued). 
Recombinant protein Cellular location Protein modification Reference 
Human insulin 
receptor cytoplasmic 
domain 
Phosphorylated Herrera et al., 195^8 
PT phlebovirus NS 
and N protein 
Cytosol Phosphorylated Ovenonetal.. 1987 
Sindbis virus capsid Cytosol Oker-Blom et al.. 
1988 
Hepatitis B virus 
core antigen 
Nucleus Lanford et al., 1987 
HTLV-I p40x Nucleus Jeang et al., 1987 
Human c-myc proto-
oncogene 
Nucleus Miyamoto et al., 
1985 
S V 40 large T 
antigen 
Nucleus Oligomerization/ 
palymitylation/ 
glycosylated/ 
phosphorylated 
Lanford. 1988 
FMDV capsid 
proteins 
Cytosol Roosien et al., 1990 
Hantann virus capsid 
Hepatitis A virus 
capsid 
Cytosol 
Nucleus 
Schmaljohn et al., 
1988 
Harmon et al., 1988 
Rotavirus VP7 
Rotavirus C486 VP7 
Bovine rotavirus 
VPl 
Cytosol/secreted 
Glycosylated 
Glycosylated 
Redmond et al., 
(1993) 
Sahara et al., (1991) 
Cohen et al., 1987 
* If blank, no protein modification has been reported. 
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EXPRESSION AND CHARACTERIZATION OF RECOMBINANT PROTEINS VP2. 
VP4, VP6, AND VP7 OF BOVINE ROTAVIRUS IN INSECT CELLS 
A paper to be submitted to the Journal of General Virology 
Young S. Lyoo, Prem S. Paul, and Alexei D. Zaberezhny 
Abstract 
The VP2, VP4, VP6 and VP7 genes of bovine rotavirus were cloned and 
expressed in insect cells using the baculovirus expression systenn, and were then 
characterized. The recombinant proteins were detected in the cytoplasm of insect cells 
infected with recombinant baculovirus by indirect immunofluorescence. Molecular mass 
of the recombinant proteins VP2, VP4, VP6 and VP7 was similar to that of wild type 
rotavirus by radioimmunoprecipitarion. Three additional minor bands were detected in 
insect cells infected with recombinant baculovirus Bac. pVLA'P4 containing the VP4 
gene of bovine rotavirus. Two bands of 60 kDa and 28 kDa were presumably VP5 and 
VPS. The thirs band of approximately 25 kDa was possibly due to the VP4 cleavage at 
amino acid 231 (arginine) suggesting that the putative cleavage site at amino acid 231 
was active. The ability of recombinant proteins to inhibit virus binding to cells was 
examined singly or in combination. Recombinant proteins VP4 and VP7 but not VP2 
and VP6 inhibited the binding of rotavirus to MA-104 cells. The antigenicity of the 
recombinant proteins was then tested in guinea pigs. All four recombinant proteins 
induced antibodies to rotavirus proteins as detected by indirect immunofluorescence test. 
Recombinant viruses Bac.pVLA'P4 and Bac.pVLATT.D induced the highest levels of 
virus neutralization antibodies, whereas Bac.pVL/VP6 induced low levels of virus 
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neutralization antibodies. In contrast, recombinant virus Bac.pBA'Pl did not induce any 
virus neutralizing antibodies. This study showed that rotavirus proteins expressed in 
insect cells using the baculovirus expression system were authentic and may have a 
potential as a vaccine for rotavirus associated gastroenteritis in calves. 
Introduction 
Bovine rotavirus (BRV), a member of the family Reoviridae and its genome is 
composed of 11 double stranded RNA segments. Electron microscopic studies revealed 
that the virus is triple layered and is approximately 70 nm in diameter (Estes, 1990). The 
virus was first isolated in the U.S. from calves with diarrhea by Mebus et al. (1969) and 
has been shown to be associated with gastroenteritis in calves, usually occurring at 1-3 
weeks of age (Bridget and Woode, 1975). Gastroenteritis has also been reproduced 
experimentally with BRV in gnotobioric, colostrum-deprived, and conventional calves 
(Bridger and Woode, 1975; Tzipori, 1981; Rewett and Woode, 1978). Modified live 
virus vaccine has been developed which appears to be effective experimentally in 
gnotobiotic calves in protection against rotavirus gastroenteritis (DeLeeuw et al., 1985; 
Saif et aL, 1990). Vaccination of dams has been a successful approach in delivering 
passive immunity to calves when evaluated under experimental and field conditions (Saif 
et al., 1984). Vaccine prepared from the NCDV strain of BRV is commercially available. 
It appears to be effective in most situations, however, vaccine breaks have been observed 
witii increased frequency. The authors believe tiiat this in part is due to serotypic 
diversity among bovine rotavirus isolates and the immunity to rotavirus is primarily 
serotype specific. Serotypes in rotavirus are determined by two surface proteins VP4 
and VF7. Rotavirus types based on VP4 and VF7 are referred to as P and G types. 
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respectively. The VP4 is protease sensitive outer capsid protein encoded by gene 4 and 
is present as a dimer in the rotavirus virion. The VP7 is a glycoprotein encoded by gene 
7, 8 or 9 depending on strains, is high in mannose and is a major neutralization antigen. 
Recent work has shown that there are three VP4 types and three VP7 types of bovine 
rotavirus. Although detailed studies on their relative prevalence is not known, rotavirus 
with P5 and G6 appear to be the most common types in calves. Some evidence suggests 
that there are additional serotypes present in the field. 
Both VP4 and VP7 induce neutralizing antibodies and are important potentially in 
protection. Antibodies in animals naturally infected with rotavirus are primarily against 
VP4, however, antibodies in animals immunized with inactivated virus are generally 
directed against VP7. Furthermore, VP4 is only a minor protein in rotavirus (Paul and 
Lyoo. 1993). Therefore, our hypothesis is that recombinant VP4 will be a good 
candidate for a vaccine. Some studies have been done in the production of bovine 
rotavirus VP4 and VP7 by recombinant DNA technology with mbced results. The VP7 
gene of the NCDV strain of BRV has been expressed in E. coli but the recombinant 
proteins did not induce neutralization activity (Fracavilla et al., 1987). Consistent results 
on ability of recombinant proteins to induce virus neutralizing antibodies have not been 
observed regardless of expression of recombinant proteins in prokaryotic or eukaryotic 
systems (Arias et al., 1986; Fracavilla et al.. 1987; Redmond et al., 1993). It has been 
speculated that correct glycosylation is essential for the production of virus neutralization 
antibodies in VP7 recombinant proteins (Arias et al., 1986; Francavilla et al., 1987). 
The VP4 gene has also been expressed in E. coli and baculovirus (Arias et al., 
1987; Mackow et al., 1989). The recombinant proteins expressed in these systems 
retained functional and antigenic properties (Mackow et al., 1989; Redmond et al., 1993) 
and were recognized by VP4-specific neutralizing monoclonal antibodies (Arias et al.. 
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1987: Mackow et al., 1989). Combination of VP4 and VP? recombinant proteins were 
suggested for vaccine composition for effective protection against the rotavirus infection 
(Redmond et al., 1993). Limited information on role of VP6 in immunity is available. 
In one study, offsprings of mice immunized with VP6 were partially protected from a 
rotavirus challenge (Redmond et al., 1993). 
This study was undertaken to express rotavirus proteins VP2, VP4. VP6, and 
VP7 from the same strain of the BRV to better characterize their role in virus binding and 
immunity. Expressed recombinant proteins were characterized and their ability to 
produce antibodies in guinea pigs was tested. Blocking of rotavirus infection with these 
recombinant proteins was also examined. These studies showed that proteins expressed 
in baculovirus expression system are authentic and antigenic. 
Materials and Methods 
Virus and cells 
The VMRI strain of bovine rotavirus (Paul et al., 1988a) was used as a parent 
virus for the cloning and expression experiments. The plaque purified virus was 
propagated in the monkey kidney cell line (MA-104) in the presence of 0.5 )ig of crystal 
trypsin (Type IX, Sigma St. Louis, MO) to improve virus replication (Theil and Bohl, 
1980; Paul et al 1988a). The MA-104 cells were washed three times with serum free 
DMEM (Gibco-BRL, Gaithersburg, MD) and inoculated with the VMRI strain of bovine 
rotavirus at 0.1 multiplicity of infection (MOD. The virus-inoculated MA-104 cells were 
incubated at 37°C for 60 minutes in a CO2 incubator with occasional rocking to increase 
attachment of the virus to cells. After incubation for 60 minutes, the viral inoculum was 
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removed and the cells were washed once with serum free DMEM to remove residual viral 
inoculum then fresh DMEM containing 0.5 (ig of trypsin was added as a maintenance 
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medium. The cells were incubated for three days in a CO2 incubator at 37 C. Rotavirus 
was extracted with 'Genetron 113' and purified on cesium chloride density gradient by 
modification of the method described by Cohen et al. (1977). The infected cell culture 
materials were frozen and ±awed three times, and the virus was then pelleted by high 
speed centrifugation for 90 minutes at 100,000 Xg (Beckman). The viral pellet was 
extracted in Genetron (l.l,2-Trichloro-l,2.2-trifluoroethane, Johnson Matthey 
Electronics, MA) and virus in the aqueous phase was collected after low speed 
centrifugation for 20 minutes at 3000 rpm. To pellet virus particles, collected supernatant 
was centrifuged for 90 minutes at 25,000 rpm and the pellets were resuspended in 500 [j.1 
of sterile deionized water. The resuspended sample was layered on a continuous cesium 
chloride density gradient (1.2-1.6 gm/ml) for further purification. After a 4 hour 
centrifugation at 100,000 Xg, the virus bands were collected and their density was 
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measured. To remove the cesium chloride the sample was dialyzed against PBS at 4 C 
overnight The virus sample was treated with EDTA at a final concentration of 50 mM 
for 2 hour at 37 C and core particles were pelleted through a 30% sucrose cushion by 
centrifugation at 25,000 rpm for 60 minutes. The pellet was resuspended with 100 jj.1 of 
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sterile water and stored at -80 C for the in vitro transcription of viral mRNA . 
Atitographa californica matrix nuclear polyhedrosis virus (Ac MNP V) and 
Trie hop lusia /u",-derived BTI-TN-5B1-4 cells (Hi-Five) were used for production of 
recombinant baculovirus and protein expression studies. For the construction of the 
transfer vector, commercial baculovirus expression system (MAXBAC™ version 1.4. 
Invitrogen corporation, San Diego, CA) was used. The linearized wild type baculovirus 
DNA or wild type baculovirus with lethal deletion was used for transfection experiments 
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(Invitrogen corporation. San Diego, CA or Pharmingen San Diego. CA). For the 
growth of insect cells, we used serum free ExceIl-400 (JRH Biosciences. Lenexa, KS) 
insect cell culture medium supplemented with antimycotic and antibiotics. Insect cells 
were detached from the surface by scraping with a soft rubber policeman and carefully 
resuspended by gentle pipetting without generating foam. 
Antiserum production 
Hyperimmune serum to the VMRI strain of bovine rotavirus was prepared by 
immunizing guinea pigs using a cesium chloride-purified VMRI strain of BRV following 
protocols described previously (Bastardo et al., 1981). The VMRI strain of bovine 
rotavirus (p 18) was propagated in MA-104 cells in the presence of 0.5 (ig of trypsin 
(Type DC, Sigma St. Louis, MO). The cell culture materials were harvested when CPE 
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reached 80 % and virus was pelleted by centrifugation at 4 C for 90 minutes at 25.000 
rpm using SW 28 rotor (Beckman Instruments. Inc.. Fullerton, CA). The pellets were 
resuspended with Tris.HCl buffer (pH 7.4) and an equal volume of Genecron-113 was 
added. This mixture was homogenized in the vertis mixer for 3 minutes twice and the 
aqueous phase was collected afte centrifugation at 2000 rpm for 20 minutes. The virus 
o 
containing aqueous phase was centrifuged to pellet the virus at 4 C for 90 nriinutes at 
25,000 rpm. The pellets were resuspended with a small volume of resuspension buffer. 
The cesium chloride gradient ranging from a density of l.l to 1.5 gm/ml was formed 
using a gradient former (Hoffer Scientific Instruments, San Francisco, CA) and 
resuspended pellets were layered on the top of the gradient To prevent evaporation. 1 
ml of mineral oU was layered on the top of the virus sample. After centrifugation at 
25,000 rpm for 60 minutes, die virus containing bands were visualized by reflecting light 
over the tube in the dark and three bands consisting of empty, double and single capsid 
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virus particles were collected. The virus in three bands was pooled and dialyzed 
extensively against PBS then inactivated by treatment with 4 mM of bromoethyleneimine 
ovemight at 37'C. The inactivated rotavirus was mixed with Freund's complete adjuvant 
(FCA, Sigma, Sl Louis. MO) and inoculated into rotavirus free guinea pigs. Three 
weeks after the first immunization, the guinea pigs were given immunogen with Freund's 
incomplete adjuvant (FICA) as a booster injection to enhance the immune response. 
Antiserum was collected at the time of first immunization and at 3 weeks after 
immunization to detect the presence of antibodies against the homologous strain of 
rotavirus. Final bleeding was carried out three weeks later and serum samples were 
separated from blood then inactivated with heat at 56 C for 30 minutes. Antibody titers 
were determined and serum samples were stored at -20 C. 
Vinis piaification and core particle preparation 
The VMRJ strain of BRV was inoculated onto monolayers of MA-104 cells in the 
presence of 0.5 jig/ml of trypsin and cells were incubated for 3 days or until CPE 
reached around 80%. Cell cultures were frozen and thawed three times to disrupt virus-
infected cells to release virus particles. The culture material was centrifuged at 25,000 
rpm for 90 minutes at 4°C and pellets were collected in sterile new tubes. The pellets 
were mixed with an equal volume of Genetron-l 13 (1,1,2-Trichloro-1,2.2-
trifluoroethane, Johnson Matthey Electronics, MA) and extracted using the vonex mixer 
for 10 minutes. The extracted material was centrifuged for 20 minutes at 3000 rpm 
(Sorvall RC5B refrigerated superspeed centrifuge, DuPont Instruments) and the aqueous 
phase was carefully decanted in sterile new tube. To pellet virus particles, virus 
containing aqueous phase was centrifuged for 90 minutes at 25,000 rpm and pellets were 
resuspended with 500 jil of sterile deionized water. The resuspended sample was 
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layered on the continuous CsCl gradient with a starting density of 1.2 to 1.4 mg/ml and 
gradients were centrifiiged at 25,000 rpm for 2 hours. The virus bands were collected 
and their density was determined by weighing 25 jil into capillary tubes. Samples were 
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dialyzed against PBS at 4 C overnight. The dialyzed virus sample was treated with 
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EDTA at a final concentration of 50 mM for 2 hours at 37 C and core particles were 
pelleted through a 30% sucrose cushion at 25,000 rpm in a SW 28 rotor for 60 minutes. 
The pellet was resuspended with 100 |il of sterile water and stored at -80 C. 
In virro transcription of rotavirus mRNA 
The viral mRNA was transcribed in vitro from purified VMRI core panicles 
containing RNA dependent RNA polymerase. The reaction mLxture was prepared in 2X 
transcription buffer (100 mM Tris.HCl, 0.5 mM NaOAc, 30 mM MgOAc. pH 8.0) 
containing ATP (8 noM), CTP (2.5 mM), GTP (2.5 mM), QTP (2.5 miVI), S-adenosyt-
methionine (0.5 m^i'I), RNase inhibitor, and purified viral cores. The tube containing the 
reaction mixture was incubated for 6 hours at 42 C and newly synthesized mRNA was 
extracted with 400 |il of a phenol/chloroform mixture. The supernatant was mixed with 
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equal volume of 4 M LiCl and incubated at 4 C ovemighL To pellet ssElNA from LiCl 
mixture, the tube was centrifuged for 15 minutes at 4 C and the pellet was washed once 
with 100% ethanol followed by washing with 70% ethanol to remove salt residues. The 
pellets were dried under vacuum and resuspended in 100 |jJ of DEPC-treated sterile water 
and stored at -80° C. 
First strand cDNA synthesis 
The first strand cDNA was synthesized using AMY reverse transcriptase using 
mRNAs from VMEU strain of BRV as a template. For the first strand cDNA synthesis. 
'I'ablc 1. Primer seciuences for PCR amplification of genes Vl'2, VIM, VFYi and VP?.* 
i'riiHcr Gene spcclllcily Sequence Ret'erences 
(icsigiiadoii and Poslliun 
1 VP2 5' end CCGf;C7/lf;rriAAGGCICAATriGCG Tian et al.. 1990. 
2 VP2 3' end ACA/lC7/ir;7TCA'IGA'IGCGC 
3 VP4 5'end ccGf;rf7f;ca;f:GGCTATAAAAT(;GcrrrGCTC Nishikavva and Gomglia, 
4 VP4 3' end ccGr;f:f;r;r:a;r:GGTCArAArrTCTAGACArTA 1988. 
5 VP4 5' end GGCr;/\7CCGGCTATAAAA'r(;GCri-CGCTC Mumnitdi el at., 1995. 
6 VP4 3' end GG<';-4/177-CGGTCACAACCTCTAGACACTA 
7 VP6 5' end GGTCaaATCCYCTCACTACGC Cohen et at.. 1984. 
8 VP6 3' end CT(U1ATCC GGCTlTTAAArGAAG 
y VP7 5' end rcGr;a;f;rrr;rGGCTiTAAAAGAGAGAATTTC Gor/.iglia et a!.. 1986. 
10 VP7 3' end ccGCfCauccac ggtcac atc at acta atcct a 
It VP7 5' end GGr,Y;/\7CrGGCnTAAAAGAGAGAAnT Minninidi el al., 1995. 
12 VP7 5' internal GGGr,Y; ATCC TATAAATATCTATGGTAITGAA 
t3 VP7 3' internal Gf;/\/\77C GGTCACATCATACTAATCr 
14 VP7 3' end GGr;/i/t77r:rrAiTTGATrGArGTAATrr 
* Sequences for restriction sites are shown in italics with underlines, and bold indicate start codon in primers. 
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we used primers specific to the 3' end of BRV genes 2,4, 6, and 9 (Table I) 
whichencode viral proteins VP2, VP4. VP6, and VP7, respectively. Microcentrifiige 
tubes and water used for mRNA transcription were treated with DEPC and autoclaved to 
eliminate RNase contamination. Viral mRNAs were resuspended in distilled water and 
divided into 11.5 |il aliquots in four 0.5 ml microcentrifuge tubes for cDNA synthesis of 
VP2, VP4, VP6. and VP7 genes. Tubes containing mRNA were heated at 65 C for 10 
minutes to remove the secondary structure followed by incubation at room temperature 
for 2 minutes. Reaction mixture was prepared by adding 1.0 |il of RNase inhibitor. 4.0 
|j.l of 100 mM dNTPs, 1.0 |i.l of 80 mM sodium pyrophosphate, 0.5 .ui of AMV reverse 
transcriptase and a gene-specific primer. Primers used for cDNA synthesis are shown in 
Table 1. These primers did not alter any sequences in the ORF of the corresponding 
genes. The tubes were gendy tapped to mix the solution then spun briefly to collect the 
reaction mixture. Tubes were placed in a 42 C water bath for 60 minutes followed by 
incubation at 95 C for 2 minutes to denature the RNA-cDNA hybrids. To increase 
efficiency of cDNA synthesis, a second round of cDNA synthesis was carried out by 
adding an additional 0.5 |il of reverse transcriptase and tubes were incubated for an 
additional 60 minutes at 42 C following heating at 95'C for 3 minutes. The reaction was 
stopped by placing the tubes on ice. After completion of cDNA synthesis, the final 
product was extracted with phenol/chloroform and concentrated by precipitation with 
ethanol and sodium acetate. The pellets were redissolved in 10 miVI Tris.HCl buffer 
containing 1 mM EDTA, pH 8.0. The first strand cDNAs were used as templates for 
PGR amplification of VP2, VP4, VP6, and VP7 genes. 
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PCR amplification of bovine rotavirus genes 
The VP2, VP4, VP6, and VP7 genes of VMRl strain of bovine rotavirus were 
amplified from cDNAs by polymerase chain reaction (PCR) using gene-specific primers 
and thermostable Taq-1 DNA polymerase (Invitrogen, San Diego, CA). Sequence of 
primer sets used for gene amplification is shown in Table 1. Reaction mixtures 
containing cDNA template, dNTPs (0.2 mM/each, Pharmacia, Piscataway, NJ), primers 
(2 |iM), MgCb (3 mM, Pharmacia, Piscataway, NJ), Taq-l DNA polymerase (2.5 U) 
and lOX PCR reaction buffer (500 mM KCl, 100 mM Tris.HCl and 1 mg/ml gelatin. pH 
8.4) were prepared in a laminar flow hood with sterile negative pressure conditions to 
prevent nonspecific DNA amplification by contamination. The contents in the tube were 
mixed by tapping and the mbes were centrifuged briefly to collect the reaction mixture on 
the bottom of the tube. Fifty }il of mineral oil (Sigma, St. Louis, MO) was overlayed to 
prevent evaporation during amplification. PCR amplification was conducted in 
9 
thermocycler (Coy, MI) with the first cycle of denaturation for 90 seconds at 94 C, 
o ^ 
primer annealing for 2 minutes at 48-54 C (depending on amplified gene) and primer 
o 
extension for 5 minutes at 72 C. Thirty amplification cycles were performed with 
denaturation at 94 C for 1 minute, primer annealing at 48 C for 90 seconds, and primer 
extension at 72 C for 2 minutes. The last cycle was the same except the extension time 
was increased to 10 minutes. The amplification products were analyzed in 1% agarose 
(FMC) gel by electrophoresis at 100 volts for I hour and the DNA bands were visualized 
by staining with ethidium bromide. DNA bands were cut out from the gels, purified 
using charged glass milk (Geneclean Kit. Bio 101, La JoUa, CA), and used for cloning 
and sequencing experiments. 
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Molecular cloning and sequencing 
The PCR amplified cDNAs for VP2, VP4, VP6 and VP7 genes of bovine 
rotavirus were inserted into multi-cloning sites of phagemid vector pKS"*". To enhance 
the ligation efficiency of vector and insert, the veaor DNA was dephosphorylated with 
calf intestinal phosphatase (Sigma, St. Louis, MO) and PCR amplified viral DNA was 
phosphorylated using protein kinase (Sigma, St. Louis, MO). The PCR amplified 
rotavirus cDNA and the vector DNA were ligated using T4 DNA ligase (Promega, 
Madison, WI). Colonies containing rotavuiis cDNA inserts were selected by antibiotic 
resistance and color selection on LB agar containing ampicillin, 5-bromo-4-chloro-3-
indolyl-P-D-galactopyranoside (X-gal) and isopropyl P-D-thiogalactopyranoside (IPTG). 
Positive colonies were picked and plasmid DNA was isolated by alkaline extraction 
method (Sambrook et al., 1989). Plasmid DNA was then cut with an appropriate 
restriction enzyme, electrophoresed in a 1% agarose gel and examined for the presence of 
insen. 
Sequencing was carried out by using Sanger's dideoxy method with Taq-1 
polymerase reaction using an automated sequencer at the Nucleic acid facility, Iowa State 
University. Initial sequencing was performed using universal and reverse primers and 
additional internal primers were designed for complete sequencing. Sequencing data 
were analyzed using computer software programs MacVector (TBI, New Haven, CT) and 
GeneWorks (IntelliGenetics, Inc., Mountain View, CA). Information obtained by 
sequence analysis was used for the construction of transfer vectors. 
ConstJiicrion of recombinant baculovinis awisfer vectors with rotavirus gene inserts 
I. Construction of baculovinis transfer vector containing VMRI VP2 gene insen 
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To construct the baculovirus transfer vector pBA/MRI.VP2, the cloned cDNA for 
VP2 gene was cut out of plasmid pKS'^A'P2 with Nhe I and Spe I restriction 
endonucleases and separated by preparative agarose gel electrophoresis. The cDNA for 
VP2 gene was purified with glass milk (Gene clean Kit, Bio 101, La Jolla, CA) and used 
for ligation with the baculovirus transfer vector pBlueBac DNA (Fig. I). Purified DNA 
was treated with Klenow and protein kinase for blunt end ligation. Baculovirus transfer 
vector pBlueBac was cut with restriction enzyme and purified by column 
chromatography using Sepharose CL-4B column. Purified DNA was precipitated in 
ethanol and treated with enzymes to make a blunt end for the ligation. BRV VP2 gene 
o 
and the transfer vector were ligated using T4 DNA ligase at 16 C ovemight and the 
ligation mixture was used for transformation of competent E. coli cells. The E. coli 
(INV-1 a F) colonies containing rotavirus inserts were confirmed by analysis of 
miniprep DNA with Pst I restriction enzyme. After selection of positive colonies the 
orientation of the VP2 gene insert in the vector was determined by restriction analysis and 
recombinant clones with correct VP2 gene orientation were selected. The selected clones 
were inoculated into 150 ml of LB broth containing 50 }ig/ml of ampicillin to inhibit 
growth of undesired organisms. The DNA for transfection was prepared by using a 
maxiprep protocol (QIAGEN, Hilden, Germany) and the concentration of DN.A. was 
determined by spectrophotometer (Perkin-Elmer. Norwalk, CT). 
2. Construction of the baculovirus tranter vector containing VP4 gene of bovine 
rotavirus 
The VP4 gene of the VMRI strain of BRV was amplified using gene specific 
primers from the first strand cDNA template. For the construction of transfer vector 
(Fig. 2), two primers with built-in restriction sites were used. The 5'-end primer with a 
Fig 1. Construction of recombinant baculovirus transfer vector pBA'MRI.VPl containing 
VP2 gene from VMRI strain of BRV showing noncoding sequences of 16 bp at the 5'-end 
and 28 bp at the 3'-end ([A]). Selected features of rotavirus VP2 are shown in ([B]). 
Abbreviations: pPH: polyhedrin promoter, MCS: mulri-cloning site; CH: charged helLx; 
HTH: helix turn helix; LZ: leucine zipper; PI kinase homology: putative nucleic acid 
binding motifs 
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[A] 
MCS 
pBlueBac 
VMRI VP2 Gene (2687 bp) 
Nhe I Start 
16 bp 
Stop Spe 
28 bp 
[B] 
VP2 
pBA^RI.VP2 
VMRI VP2 Gene 
1 53 77 102 154 
1 h+H h 
17 bp 
536 557 665 686 880 
2662 
CH BASIC 
66_i2l 
HTH 
64 76 
LZ LZ 
PI kinase homology 
Fig. 2. Construction of recombinant baculovinis transfer veaor p VL/VMRI.VP4 
containing VP4 gene of VMRI strain of BRV ([A]). Selected features of rotavirus VP4 
gene are shown under ([B]). The sequence of 9 bp at 5'-end and 25 bp at 3'-end 
represents noncoding sequences in the VP4 gene of the VMRI strain of BRV. The closed 
triangle at the amino acid position 306 represents epitope I, and at amino acid 392-439 
represent epitope H. Syntheric peptide corresponding to amino acids 232-255 are known to 
induce neutralization antibodies. Putative proteolytic enzyme cleavage sites are located at 
amino acid residues 241,246 and 247. An additional cleavage site was detected at aa 231. 
Abbreviations: B: Bam HI restriction cleavage sequence; E: Eco RI restriction cleavage 
sequence; pPH: polyhedrin promoter; MCS; multi-cloning site; V: variable region; C; 
constant region; Cy: conserved cysteine; ft: conserved proline; HR: heptad repeat 
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[A] 
MCS 
[ pVL1393 ] 
[B] 
VP4 
VMRI VP4 Gene (2362 bp) 
B Start 
9 bp 
pVLA^MRI.VP4 
VMRI VP4 Gene 
Stop 
25 bp 
I 71 
I h 
10 bp 
2(14 224 236 257 271 384 404 494 554 580 610 776 
1 
2337 bp 
Cv Cv 241 Tcy CyPr 
71 204 
C 246 C 306 
247 
high sequence 
variation 
Fusion 
domain 
392 439 
HR 
232 255 
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built-in Bann HI restriction endonuclease cleavage site was 
CCGGCArCCGCTATAAAATGGCTTC GCTC and the 3'-end primer with Eco EU 
restriction endonuclease cleavage site was CCGGAATTC GGTCACAACCTCT 
AGACACTA. The two restriction sites used corresponded to the available restriction 
sites in baculovinis transfer vector pVL1393 (Fig 2). The PCR amplified VP4 gene 
products were digested with Bam HI and Eco EU and then purified using sepharose CL-
4B column. Baculovirus transfer vector was cutwith Bam HI and Eco RJ then purified 
as described for the PCR amplified VP4 gene DNA. Recombinant E. coli colonies 
containing rotavirus VP4 gene inserts were selected by restriction analysis of plasmid 
DNA. Three colonies were selected and DNA from three recombinant plasmids was 
purified by passing through columns (Qiagen, Hilden. Germany) and used for 
transfection. Concentration of each DNA was measured by spectrophotometry at 260 nm 
(Sambrook et al.. 1989). 
3. Construction of a baculovinis n-ansfer vector containing the VP6 gene from the VMRJ 
strain of bovine-rotavinis 
The recombinant baculovirus transfer vector pVLAT'6 containing the VP6 gene 
of the VMRI strain of BRV was constructed using the VP6 gene cloned in plasmid (Fig. 
3). The VMRI VP6 cDNA insert was cut out of plasmid DNA with Bam HI and isolated 
by preparative agarose gel electrophoresis. DNA was purified using glass niilk 
(Geneclean Kit, Bio 101, La JoUa, CA) following manufacturer's instructions. The 
isolated VP6 gene DNA was precipitated in ethanol and ligated into baculovirus transfer 
vector pVL1393 at the Bam HI site. The direction of the VP6 gene insert in baculovirus 
transfer vector was determined by restriction analysis. Clones with correct orientation 
Fig. 3. Construction of recombinant baculovirus transfer veaor pVLA'MRI.VPS 
containing VMRI VP6 gene ([A]) and selected features of VP6 gene of group A rotavirus 
([B]). The sequence of 23 bp at the 5'-end and 139 bp at the 3'-end represent the non-
coding sequences of the VP6 gene of VMRI strain of BRV. Abbreviations: B: Bam HI; 
pPH: poiyhedrin promoter; MCS: multi-cloning site; Hy: hydrophilic region; Dashed line: 
hydrophobic regions; ssp: single shelled particle. 
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[A] 
MCS 
pVLl393 
VMRIVP6Gene (1356 bp) 
B Start 
23 bp 
Stop B 
139 bp 
[B1 
VP6 
I 20 
24 bp 
pVL/VMRI.VP6 
VMRIVP6 Gene 
90 105 150 370 397 
1217 bp 
Hv, 
105 Trimerization domain 328 
1 Conserved in A & C 140 251 ssp assembly domain 397 
353 394 
Conserved 
in A & C 
Fig. 4. Construction of recombinant baculovirus transfer vector pVLA^RI-VP? 
containing VP7 gene of VMRI strain of bovine rotavirus ([A]), and selected features of 
group A rotavirus VP7 gene ([B]). The 48 bp at the 5'-end and 35 bp at the 3'-end 
represent non-coding sequences of the VP7 gene of the VMRI strain of BRV. 
Abbreviations: pPH: polyhedrin promoter, MCS: multi-cloning site; HI, H2: two amino-
terminal hydrophobic signals; AQ: signal is cleaved between alanine (A) and glutamic acid 
(Q); C: cysteine; A, B and C: three major antigenic regions; (G): glycosylation site; CA: 
putative cell attachment domain 
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VMRI VP7 Gene (1063 bp) 
pVLl393 
VMRI VP7 Gene 
pVLA^IRI.VP? 
[B] 
VP7 
1 30 33 48 
I IH h 
124 155 192 231 278 309 326 
—i h 
49 bp 1029 bp 
M AO(G) C CCCCC CC 
Ca++ binding 
87 A 101 
145 B 152 
Conserved 
A.B&C 
Conserved 
A.B&C 
211 C 223 275 CA 295 
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were selected and DNA samples for transfection were prepared by passing through 
QIAGEN column. Concentration of DNA was measured by spectrophotometry. 
4. Consmicrion of the baculovims transfer vectors containing VP7 gene of bovine 
rotavirus 
The VP7 gene of the VMRI strain of BRV was amplified by PGR using a gene 
specific primer set with built-in restriction sites. The amplified DNA product was 
purified by spin columns (Linkers 6 Quick spin column Sepharose GL-6B. Boehringer 
Mannheim Biochemicals, Indianapolis, IN) to remove protein and oligos followed by 
ethanol precipitation. As shown in Fig. 4 the purified PGR products were inserted into a 
baculovirus transfer vector pVL1393 and clones containing inserts were identified by 
restriction analysis. DNA was prepared from selected clones and concentration was 
measured by spectrophotometry. 
Transfection and detection of expressed recombinant viral proteins by IF A 
To generate recombinant baculovirus containing bovine rotavirus genes, insect 
cells were transfected with DNA from wild type baculovirus Ac MNP V and a 
recombinant transfer vector. For the generation of a recombinant baculovirus 
Bac.pBA'^P2, 500 ng of pBA^Rl.VP2 DNA was mixed with 1 |ig of linearized 
AcMNPV DNA (Invitrogen. San Diego, GA) and lipofectin (Gibco-BRL. Gaithersburg, 
MD) solution. For other experiments, baculovirus DNA with a lethal deletion 
(PharMingen, San Diego, GA) was used to avoid generation of occlusion positive wild 
type baculovirus. For these experiments, 500 ng of each recombinant transfer vector 
DNA containing bovine rotavirus VP4 (pVLA'MRI.VP4), VP6 (pVLA'MRI.VP6). or 
VP7 (pVLA/^MRl.VP?) genes and 50 ng of wild type baculovirus DNA were mixed into 
lipofection (Gibco-BRL, Gaithersburg, MD) solution in separate tubes containing 
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different genes. The plasmid DNA and baculovirus DNA mLxtures were incubated for 15 
minutes at room temperature. Meanwhile, the insect cells were plated in 6-well cell 
culture clusters at a concentration of 3X10^ cells/ml and the plates were placed in a 
laminar flow hood at room temperature for 60 minutes to allow the cells to attach onto the 
plastic surface. After incubation for 60 minutes at room temperature, the cell culture 
medium (Excell-400, JRH Bio Sciences, Lenexa, KS) was replaced and a DNA/ 
lipofection mixture was added drop by drop. For efficient transfection. cells were placed 
at room temperature for 4-6 hours depending on the condition of the cells. The 
transfection material was removed and 3 ml of fresh insect cell culture medium (Excell-
400) was added. The cell culture plates were incubated at 27°C for 72 hours. 
Plaque purification of recombinant viruses 
Plaque purification was performed to isolate pure clones of recombinant 
baculoviruses. Insect cells infected with recombinant virus were harvested and culture 
materials were clarified by low speed centrifugation at 2000 rpm for 20 minutes at 4°C. 
Supematants were collected in sterile snap cap tubes (Falcon, Lincoln Park, NJ) and 
serially diluted ten fold from 10"^ to 10"^. Diluted inocula were added onto insect cells 
and incubated for 60 minutes at room temperature to allow infection of insect cells with 
the recombinant virus. After a 60 minute incubation, the inocula were removed and 3 ml 
of 1.25% Sea Plaque agarose (FMC, Rockland, ME) prepared in Excell-400 insect cell 
culture medium was added. After solidification of agarose, 3 ml of insect cell culture 
medium Excell-400 was added on agarose to prevent drying during further incubation 
0 
period. Cells were incubated for 72 hours at 27 C without a CO2 supply. Occlusion 
negative isolated virus plaques were picked using sterile Pasteur pipettes and diluted in 
0.5 ml of insect cell culture medium. Recombinant virus containing tubes were stored at 
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4 C overnight to release virus particles into the media and then centrifuged at 2000 rpm 
for 10 minutes at 4 C. This purification step was repeated three tmies to ensure clonal 
population. The plaque purified recombinant baculoviruses were designated as 
Bac.pBA'P2, Bac.pVL/VP4. Bac.pVLA'P6, and Bac.pVL/VP7 containing VP2, VP4. 
VP6 and VP7 genes, respectively. After three rounds of purification, supematants 
containing recombinant bacuiovirus were collected and stored at -80 C 
Detection ofrotaviral genes in recombinant baculovints by dot blot hybridization assay 
The presence of a rotavirus gene in recombinant bacuiovirus was determined by a 
dot hybridization assay using radiolabeled probes. To extract the nucleic acid, insect 
cells were fi-ozen and thawed once and clarified by low speed centrifugation. 
Recombinant baculoviruses were pelleted fi-om supernatant by centrifugation at 37.000 
rpm for 90 minutes using SW 41 rotor and viral DNA was extracted with 
phenol/chloroform. The aqueous phase was collected and DNA was precipitated with 
ethanol at -70 C and collected by centrifugation. DNA in pellets was resuspended and 
nucleic acid was denatiu^ed by boiling for 5 minutes followed by chilling on ice 
immediately to avoid renaturation. Insect cells infected with wild type bacuiovirus, 
treated siinilar to those infected with the recombinant bacuiovirus, were used as a 
negative control. Recombinant phagemid DNA containing bovine rotavirus VP2. VP4. 
VP6, or VP7 genes of bovine rotavirus were applied on the same membrane and used as 
positive controls. The phagemid vector pKS"*" DNA without an insert was also added on 
the same membrane as a negative control. 
Denatured nucleic acid solutions were applied on a nylon membrane (Bio-Rad 
Laboratories, Hercules, CA) using a 96-well manifold (Bio-Rad Laboratories, Hercules, 
CA) and baked for 2 hours at 80 C to immobilize nucleic acids. Membranes were 
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prehybridized for 4 hours at 65 C in prehybridization solution containing 5X Denhardt's 
solution. 6X SSC and denatured salmon testes DNA. Fifty ng each of PGR amplified 
cDNA corresponding to VP2, VP4, VP6, and VP7 genes of bovine rotavirus were 
labeled in separate reaction mixture with [a^^P]dCTP (ICN Biochemicals, Costa Mesa. 
CA) in the presence of a random hexamer and a Klenow fragment of DNA polymerase 1 
(Amersham Corporation. Arlington Heights. IL). Radiolabeled DNA was passed 
through the column (Linkers 6 Quick spin column Sepharose CL-6B. Boerringher 
Mannheim, Indianapolis, IN) to remove unincorporated [a-^-P]dCTP. and just prior to 
Q ^ 
hybridization boiled for 5 minutes at 100 C and placed on ice. Radiolabeled probes were 
added into each hybridization roller bottie containing the membrane and hybridized 
overnight in a hybridization chamber at 65°C (Hybaid, Valley Park, MO) with a rolling 
speed of 10 rpm. To remove unincorporated radiolabeled probes, the membranes were 
washed three times in IX SSC-0.1% SDS. three times in O.IX SSC-0.l% SDS and 
three times with sterile water at 65 C. An autoradiograph was made by exposing X-ray 
film (Kodak, Rochester, NY) to the hybridization membrane. 
Detection for the presence ofrotaviral genes in recombinant virus by PCR amplification 
To confirm the presence of rotavirus genes in recombinant baculoviruses. PCR 
was performed using rotavirus gene specific primers. Insect cells were infected with 
wild type baculovirus or one of the recombinant baculoviruses Bac.pBA^2, 
Bac.pVLA^4, Bac.pVLA'P6, and Bac.pVLA^. Total nucleic acid was isolated and a 
rotavirus specific gene was amplified using gene-specific primer sets for VP2, VP4, VP6 
and VP7 (Table 1). The PCR amplified product was analyzed by agarose 
electrophoresis. The PCR conditions were as described in the previous section. 
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Detection of rotavirus proteins by indirect immiuioflnorescent antibody rest 
Indirect immunofluorescent antibody tests were performed to detect rotavirus 
specific recombinant proteins in insect cells infected with recombinant baculovirus. Cells 
infected with the wild type baculovirus or mock infected cells were used as controls. 
Monolayers of insect cells were infected with recombinant baculovirus, incubated at 27°C 
for 72 hours after infection at which time they were fixed with cold methanol at room 
temperature for 15 minutes. Guinea pig antiserum to VMRI strain of bovine rotavirus, 
which had been tested for rotavirus specificity, was used to detect rotaviral antigens. 
9 
Cells were incubated with serum for 60 minutes at 37 C at which time they were washed 
three times with PBS to remove unbound antibodies. nTC-labeled anti-guinea pig 
antibodies (Kirkegaard & Perry Laboratories Inc., Gaithersburg, MD) were applied and 
incubated for 30 minutes at 37 C. The cells were rinsed three times with PBS. and 
examined under fluorescent microscope. Photographs were taken using Olympus BH-2 
UV microscope with an automatic exposure control unit. 
Tin-arion of recombinant bacidovimses 
Titers of recombinant baculoviruses Bac.pBAT'2, Bac.pVLAT4, Bac.pVLA'^P6. 
and Bac.pVLA'P7 were determined in BTI-TN-5BI-4 cells by indirect 
immunofluorescent assay. Briefly, insect cells were split into 96-well tissue culture 
plates (Coming Incorporated, Coming, NY) and left undisturbed to allow attachment of 
the cells to the plastic surface. After 60 minutes incubation, the medium was removed 
and lO-fold dilutions of recombinant virus were added into 4 weUs per sample. Cells 
were incubated for 60 minutes and medium was decanted. Cells were further incubated 
for 72 hours at 27 C then fixed with cold methanol for 15 minutes. Cells were reacted 
with hyperimmune guinea pig anti-VMRl rotavirus hyperimmune serum in an indirect 
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immunotluorescent tesL Reciprocal of the highest dilution that gave positive 
immunofluorescence was considered as the virus titer and the virus titer was expressed as 
fluorescent focus units (FFU) per ml. 
Kinetics of recombinant rotavinis protein expression in insect cells 
To test the kinetics of recombinant protein expression, insect cells were infected 
with recombinant baculovirus Bac.pBA'P2, Bac.pVLA^4, Bac.pVL/VP6, or 
Bac.p VLA'PV. The insect cells were labeled with -methionine/cysteine at 24.48, 72 
and 96 hours post infection and immunoprecipitated with anti-VMRI hj^erimmune 
serum . Insect cells prepared in 24-well tissue culture plates were inoculated with wild 
type or recombinant baculovirus and metabolically labeled with 200 }iCi of ^^S-
methionine/cysteine. Supernatant and cells were collected separately at each time point to 
examine the presence of recombinant proteins in cells and secreted proteins in culture 
medium. The tubes containing supernatant were centrifuged for 2 minutes in 
microcentriftige and the pellets were discarded to eliminate cell contamination. The 
supernatant was mixed with an equal volume of lysis buffer and vonex mixed for 2 
minutes, then placed on ice for 3 minutes. Cells were lysed with 0.5 ml of lysis buffer 
and processed as described for the supernatant. Radioimmunoprecipitation was carried 
out as described under the previous section. Gels were dried under vacuum and X-ray 
film was exposed to iL Images on X-ray film were traced on a transparency film and 
rotavirus specific bands in gel were located by overlaying the transparency film on dried 
gel. The bands were cut and radioactivity was measured using liquid scintillation 
counter. 
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Vinis-like panicle (VLP)fonnatton 
To determine the combinadon of rotavirus proteins that were necessary for virus­
like particle (VLP) formation, insect cells were infected with different combinations of 
recombinant baculoviruses Bac.pBA^2, Bac.pVL/VP4, Bac.pVL/VP6, and 
Bac.pVLAT^T. Mock infected and wild type baculovirus infected insect cells were used 
as controls. Insect cells infected with recombinant baculovtrus were colleaed at 6 days 
o 
post inoculation and stored at 5 C overnight Cell culture materials were centrifuged at 
25,000 rpm for 6 hours at 5 C and supematants were decanted. Pellets were 
resuspended with 50 mM TE buffer and extracted with Genetron (1,1.2-Trichloro-1,2,2-
trifluoroethane, Johnson Matthey Electronics, MA) for 15 minutes on a vortex mixer. 
The virus and Genetron mixture was centrifuged at 5,000 rpm for 30 minutes at 5 C. 
The virus containing supematants were collected into new sterile tubes for each sample 
and examined by immune electronmicroscopy. Ten ml of the supernatant was mixed 
with 50 jil of polyclonal guinea pig anti-VMRl hyperimmune semm and incubated 
overnight at 5°C. To pellet the virus and antibody complexes, samples were cenoifuged 
o 
at 35,000 rpm for 90 minutes in a SW 41 rotor at 5 C. The supematants were discarded 
and 500 |ii of sterile water was added into each tube to resuspend pellets. After 
overnight incubation, pellets were transferred to 1.5 ml microcentrifuge tubes and 
centrifuged for 5 seconds to remove large size debris. Clear supematants were stained 
with 17c potassium tungstic acid (PTA) and sprayed on grids using a nebulizer and 
examined under an electron microscope (Hitachi 500, Japan). 
Radioimmunoprecipirarion 
Radioimmunoprecipitation was carried out to identify the expressed recombinant 
protein and to determine its molecular mass. Insect cells were inoculated with wild type 
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baculovirus, recombinant baculovirus Bac.pBA'^Pl, Bac.pVLA^P4, Bac.pVLA''P6, or 
Bac.p VL/VP7. Three days after inoculation, nnethionine free insect cell culture medium 
(Gibco-BRL, Gaithersburg, MD) was added for 2 hours followed by addition of 200 
fiCi of 3^5-methionine (ICN, Costa Mesa, CA). Cells were labeled for 2 hours at 28 C. 
Guinea pig and-VMRI serum was pre-treated with cold cell lysate from insect cells 
infected with wild type baculovirus for I hour at room temperature to eliminate non­
specific binding. To prepare cold lysate, insect cells were infected with the wild type 
« 
baculovirus and incubated at 27 C for 72 hours. After removal of supernatant from 
flask, 2.5 ml of lysis buffer (1% NP40. 50 mM NaCl, 50 mM Tris/HCl. 0.5 ug/ml 
Leupeptin , 100 |ig/ml phenylmethylsulfonyl fluoride (PMSH. and 1 |ig/ml Pepstatin A, 
pH 8.0) was added into each flask and flasks were incubated at room temperature for 5 
minutes. The lysed cells were collected into 1.5 ml microcentrifuge tubes and vortex 
mixed for 3 minutes then incubated for 3 minutes on ice. Cell debris was removed by 
0 
centrifugation and supernatant was saved as a cold lysate at -80 C. Hot lysate was 
prepared as described previously (O'Reily et al.. 1992). For radioimmunoprecipitation. 
50 jil of the serum treated with cold lysate was added into 100 |il of hot lysate and the 
9 
lysate-serum mLxture was incubated overnight at 4 C to form an immune complex. To 
capture the immune complex, 100 |il of CL-4B bound protein A. (Sigma, Sl Louis, MO) 
was added and mixed by rotating for 1 hour at room temperature. Protein-A-bound 
immune complexes were washed three times with lysis buffer and an additional three 
rimes with sterile water. Samples were mixed with 50 |il of sample buffer then boiled 
for 5 minutes just before analysis by gel electrophoresis. An X-ray film was exposed to 
the dried gel and results were analyzed. 
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Target receptor blocking assay using recombinant proteins 
To identify rotavirus protein (s) which bind to target cells, recombinant proteins 
were used to block target receptors on MA-104 cells. Lysates of insect cells, wild type 
baculovirus or recombinant baculovirus Bac.pBAT2, Bac.pVLA^4, Bac.pVLAT6. or 
Bac.pVLA'P? were prepared as described previously (Bass et al. 1991). To determine 
saturation point for receptor blocicing, 10-fold dUudons of lysates of insect cells infected 
with recombinant baculovirus Bac.pVL/VP4, and Bac.pVL/VP7 were added onto MA-
104 cells. 
Monolayers of MA-104 cells at 65-70 passage level were grown in 24-well tissue 
culture plates and washed three times with serum-free DMEM. Cells in two control wells 
were trypsinized and the number of cells were counted. Concentration of MA-104 cells 
was 1X10^ cells/well. One ml lysate of cells infected with different recombinant 
baculovirus was added into each well. TTie tissue culture clusters were further incubated 
for 2 hours at 37 C and washed gendy three times with serum-free DMEM. Cells were 
inoculated with 100 ETU of the VMRI strain of BRV at passage 19. Cells were 
incubated for 60 minutes at 37 C and washed three times to remove the virus inoculum. 
Maintenance medium containing 0.5 jig/ml of trypsin was added and incubated for 18-20 
hours at 37 C. The cells were fixed with cold methanol and the number of rotavirus 
specific foci were determined by the indirect immunofiuorescent test Rotavirus specific 
foci were counted three times from duplicate wells infected with 100 FTTJ and the data 
reported as an arithmeric mean of two experiments. 
To examine the effect of trypsin treatment on receptor binding, recombinant 
baculoviruses were treated with 5 |ig/ml of trypsin and their ability to block receptor 
binding was measured. 
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Preparation ofimmunogen 
For the preparation of the immunogen. recombinant baculoviruses were 
propagated in insect cells individually or in combination. Briefly, insect cells were 
detached by a mbber policeman and plated at a cell concentration of 2.5x10^ cells/ml. 
Cells were allowed to attach to the surface of culture vessel for 1 hour at which time the 
culture medium was removed and replaced with recombinant baculovirus at a MOl of lU. 
After one hour, the medium was removed and fresh insect cell culture medium was added 
and cells were further incubated at 2TC. When CPE reached X0%, usually in about 4 to 
5 days post infection, the cells were frozen and thawed three times and used as 
immunogen. One ml of immunogen was emulsified with 10% of Freund's incomplete 
adjuvant (Sigma, St. Louis, MO) in the presence of RAS (MPL+TDM+CWS Emulsion, 
RiBI [mmunoChem Research Inc, Hamilton. MT) to enhance immunogenicity of 
recombinant proteins. 
Antigenicity of recombinant proteins in guinea pigs 
Guinea pigs were inoculated with lysates of insect ceUs infected with recombinant 
baculovirus Bac.pBA'P2, Bac.pVLA'P4, Bac.pVLAnP6, or Bac.pVL/VP7. Preimmune 
serum samples were collected from guinea pigs and tested for antibodies to rotavirus. 
Recombinant viruses were propagated singly or in combination, on insect cells. Virus 
preparations were inactivated with 4 mM bromoethyleneimine (BEI) for 1 hour at 37°C. 
Sodium thiosulfate was added at a final concentration of 40 mM to neutralize BEI before 
immunization. Inactivated VMRI strain of bovine rotavirus grown in MA-104 cells, 
uninfected BTI-TN-5B1-4 cell culture material and BEI-inactivated wild type baculovirus 
AcMNPV grown in BTI-TN-5B1-4 cells were also prepared as control antigens. 
Antigens were emulsified with adjuvant and inoculated into guinea pigs by intramuscular 
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and subcutaneous routes. Guinea pigs were anesthetized with acepromazine and 
ketamine nnLxture and blood sample was collected from each individual guinea pig one 
day before immunization. Serum samples were tested for the presence of antibody to 
rotavirus by indirect immunofluoresence. Blood samples were collected at 3 weeks after 
the first immunization and the guinea pigs were given a booster injection. Three weeks 
later, final blood samples were collected and serum samples were stored at -20°C. 
Detection of immune response 
To detect the immune response to recombinant rotavirus proteins, serum samples 
were tested for antibodies by an indirect immunofluorescent assay and a virus serxim 
neutralization test using the VMRI strain of BRV. Semm samples were heat inactivated 
o 
for 30 minutes at 56 C, before tests. For the indirect immunofluorescent test serial 
dilutions of semm samples were applied onto rotavirus-infected and methanol-fixed 
MA 104 cells. ETTC-labeled secondary antibody was then added to examine rotavirus 
specific fluorescence with fluorescence microscope. For virus serum neutralization test, 
cells were grown in 96-well plates and infected with the VMRI strain of BRV. Serially 
diluted serum samples were mixed with 200 TCIDso/ml of VMRI strain of BRV and 
o 
incubated for 60 minutes at 37 C. The serum and virus mixture were inoculated onto 
a 
monolayers of MA-104 cells and incubated at 37 C. .After 60 minutes of incubation, 
inocula were aspirated and cell monolayers were washed once with semm-free DMEM. 
Serum-free DMEM containing 0.5 |ig/ml of trypsin was added into each well and cells 
were further incubated for 24 hours at 37 C. The cells were fixed with cold methanol for 
15 minutes at room temperature and then stained to examine rotavirus specific 
immunofluorescence. Reciprocal of the last dilution of serum that neutralized virus i.e. 
gave negative fluorescence was considered as a virus serum neutralization titer. 
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Results 
Cloning of rotavirus genes and construction of transfer vectors 
The cDNAs for VP2, VP4, VP6, and VP7 genes of the VMRI strain of BRV 
were synthesized by reverse transcription, amplified by PGR using gene-specific primers 
and cloned into phagemid vector pRS"*". The recombinant colonies were identified by 
color selection and recombinant plasmids were examined for the presence of inserts by 
restriction endonuclease analysis. As expected, the size of cDNA inserts for VP2, VP4, 
VP6, and VP7 genes was 2.69, 2.36, 1.36, and 1.06 kb. respectively (Fig. 5). The 
cDNA from recombinant plasmids containing VP2 gene was released and subcloned into 
baculovirus transfer vector pBlueBac as illustrated in Fig. 1. The cDNA from the 
recombinant plasmid with the VP6 insert was released and subcloned into baculovirus 
transfer vector pVL1393 (Fig. 3). The PGR amplified cDNAs of VP4 and VP7 genes 
were cloned into a baculovirus transfer vector pVLl393 (Fig. 2 and 4). The presence of 
the inserts in baculovirus transfer vectors was confirmed by restriction endonuclease 
digestion and size of released some fragments were different from original inserts due to 
the restriction enzymes used (Fig. 6). 
Production of recombinant baculovirus containing VP2, VP4, VP6 and VP7 genes of 
bovine rotavirus 
Recombinant bacuioviruses were prepared by co-transfection of insect cells with 
DNA from wild type baculovirus and recombinant plasmids. Occlusion negative plaques 
were picked, and purified by three rounds of plaque purification. Presence of cDNA 
inserts in baculovirus was confirmed by dot blot hybridization and PGR (Fig. 8 and 9). 
Fig. 5. Cloning of bovine rotavirus VP2, VP4, VP6, and VP7 genes into phagemid vector 
pKS"^. Genes were released using appropriate restriction endonuclease. DNA from VMRl 
VP2 gene of 2.7 kb (lane 2), VP4 gene of 2.4 kb (lane 4), VP6 gene of 1.3 kb (lane 6) and 
VP7 gene of 1.06 kb (lane 9) were separated on 1% agarose gel electrophoresis at 100 volt, 
stained with ethidium bromide, and visualized under ultra violet light. 
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Fig. 6. Recombinant plasmids containing rotavirus genes VP2, VP4, VP6 and VP7 cloned 
in baculovirus transfer vector. Insert DNAs were released from recombinant plasmid with 
restriction endonucleases. The cDNAs from recombinant plasmids pBA'MRI VP2 digested 
with restriction enzyme Pst I Qane 2), pVLA^MRI VP4 digested with restriction enzymes 
Bam HI and Eco RJ Qane 4), pVLATVtRI VP6 digested with restriction enzyme Bam HI 
(lane 6), pVLA^MRI VP7 dgested with restriction enzymes Bam HI and Eco EU (lane 9), 
and I kb size marker (Lane L) were analyzed by gel electrophoresis. 
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Fig. 7. Insect cells BTI-TN-5B1-4 infected with recombinant baculoviruses Bac.pBA^2 
(2), Bac.pVLA'P4 (4), Bac.pVLA'P6 (6), Bac.pVLAT? (7), wild type baculovirus 
AcMNPV (W) or insect cell control (H). Cytopathic effect of recombinant virus 
Bac.pVLA^4 showed extensive fusion activity and Bac.pVLAT^ recombinant showed 
moderate fusion activity. Recombinant baculoviruses Bac.pBA'^P2 and Bac.pVL/6 did not 
show any fusion activity in insect cells. The occlusion positive wild type baculovirus 
showed polyhedra in insect cells. 
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Recombinant baculoviruses were purified by three rounds of plaque purification and 
positive clones were selected for the presence of occlusion negative CPE (Fig. 7). 
Further confirmation was done by indirect immunofluorescence by staining with hyper­
immune serum to the VMRI strain of BRV (Fig. 10). 
Detection of rotavirus specific nucleic acid in recombinant baculoviruses 
Nucleic acid from recombinant baculoviruses Bac.pVLA^2. Bac.pVL/VP4, 
Bac.pVLAT6 and Bac.pVLAT? were hybridized with probes derived from their 
corresponding genes. The VP2 gene probe only reacted with nucleic acid from insect 
cells infected with Bac.pBA'^Pl but not with nucleic acid from cells infected with wild 
type baculovirus or other recombinant baculoviruses. Similary, VP4. VP6 and VP7 
genes specifically hybridized to nucleic acid from cells infected with recombinant 
baculovirus Bac.pVLA^P4, Bac.pVLA^6 and Bac.pVLA'PT, respectively. As a control 
pKS"^ vectors containing VP2, VP4, VP6 and VP7 genes showed strong positive signals 
with corresponding gene probe, but the probes did not react with vector without insert 
(Fig. 8). 
Characterization of recombinant baculovirus and proteins expressed in insect cells 
All recombinant baculoviruses were cytolytic and plaques were occlusion 
negative. Based on cytopathic effects in insect cells recombinant baculoviruses 
Bac.pBA^P2 and Bac.p VLA'P6 did not posses any fusion activities in the insect cells 
infected with those recombinant baculoviruses. Insect cells infected with recombinant 
virus Bac.pVLA^4 showed extensive cell fusion activity (Fig. 7). The recombinant 
virus Bac.pVLAT^ also showed weak fusion activity in insect cells which was not 
expected from the VP7 proteins. But there is no clear evidence which protein(s) are 
Fig. 8. Dot hybridization of nucleic acids from insect cells infected with recombinant 
baculovirus with a3-P[dCTP] labeled gene specific probes of bovine rotavirus. 
Nucleic acid from insect cells infected with Bac.pBA^2 (2A and 2a), Bac.pVL/VP4 (4A 
and 4a), Bac.pVLA'^P6 (6A and 6a), Bac.pVLA'^ (7A and 7a), wild type baculovirus 
AcMNPV (WA and Wa), phagemid vector pKS"*" (PA), and phagemid vector (Pa) with 
corresponding gene insert were applied on nylon membrane and hybridized. Probes used 
were from VP2 gene (R2), VP4 gene (R4), VP6 gene (R6) or VP7 gene (R7). 
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Fig. 8. (Continued). 
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Table 2. Titers of recombinant viruses and occlusion positive baculovirus AcMNPV. 
Recombinant Viruses Titers 
Bac.pB/VP2 107-5 FFU/ml 
Bac.pVL/VP4 108.0 FFU/ml 
Bac.pVL/VP6 108.5 FFU/ml 
Bac.pVL/VP7 lOS-O FFU/ml 
AcMNPV 108-5 TCIDso/ml 
VMRI 106.0 FFU/ml 
* All recombinant baculoviruses were titrated in insect cells, whereas VMRI strain of 
bovine rotavirus was titrated in MA-104 cells by indirect immunofluorescence. 
responsible for receptor binding. Rotavirus specific insens in recombinant baculoviruses 
were confirmed by PCR amplification using specific primer sets to the corresponding 
genes. Inserts of 2.7 kb, 2.36 kb. 1.36 and 1.1 kb DNA were amplified from insect 
cells infected with recombinant baculoviruses Bac.pBA^2, Bac.pVLA'P4, 
Bac.pVLA'P6 and Bac.pVLA^7, respectively (Fig. 9). 
Titers of recombinant viruses Bac.pBAT'2, Bac.pVL/VP4, Bac.pVLA''P6, and 
Bac.pVLA'^P7 were determined in insect cells BTI-TN-5B1-4 (Table 2). As a control, 
wild t>'pe baculovirus AcMNPV was also titrated under the same conditions. Titers of 
these recombinant viruses are shown in Table 2 and were titrated by an indirect 
immunofluorescent assay using guinea pig hyperimmune serum to the VMRI strain of 
BRV. The wild type baculovirus titer was determined by CPE with formation of typical 
polyhedron in insect cells (Fig. 7). Recombinant vims titers were 10^-5 FFU/ml for 
Bac.pBA^P2. lO^-O FFU/ml for Bac.pVLA'P4, 10^-5 FFU/ml for Bac.pVL/VP6 and 
Fig. 9. PGR amplification of bovine rotavirus VP2, VP4, VP6 and VP7 genes from insect 
cells infected with recombinant baculovirus Bac.pBA^ (lane 2), Bac.pVLAT'4 (lane 4), 
Bac.pVLA'P6 Oane 6). Bac.pVLAnP? (lane 9), and wild type baculovirus AcMNPV (lane 
W). Lane L contains 1 kb size markers. The VP2, VP4, W6 or VP7 gene-specific 
primers (Table 1) were used for PGR amplification 
1 - 2  4  6  g  w  
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108.0 FFU/ml for Bac.pVL/VP7. respectively. There was no significant difference in 
virus titers among recombinant viruses. As a control, the titer of wild type baculovirus 
was determined by the presence of occlusion positive CPE in insect cells. As shown in 
Table 2 the wild type baculovirus titer was 10°-^ TCID50/ml by CPE, and the titer of 
VMRI strain of BRV in iVIA-104 ceils was lO^-O ETU/ml using an indirect 
inuTiunofluorescent test (Fig. 10). The titers of the recombinant viruses were slightly 
lower than that of the wild type baculovirus. Recombinant virus titers in insect cells were 
about 2 log 10 higher than that of the VMRJ strain of BRV in iVIA-104 cells. 
Characteristics of recombinant proteins 
Radioimmunoprecipitation was carried out to characterize expressed recombinant 
proteins. The molecular mass of the recombinant protein VP2 expressed in insect cells 
infected with recombinant virus Bac.pBA^P2 was 102.4 kDa. An additional slower 
migrating minor band of approximately 115 kDa was observed (Fig. 11-R2). 
Recombinant baculovirus Bac.pVLA''P4 gave a heavy precipitate of an 87 kDa 
polypeptide band and additional weak bands which migrated faster than the VP4 
recombinant protein and had a molecular mass of 60 kDa and 28 kDa. These bands 
presumably are VPS and VP8, the cleaved products of VP4. This cleavage might occur 
due to the presence of cellular proteoljmc enzymes. The molecular mass of VPS 
corresponded to that of the NCDV VPS protein which is located on the amino terminal 
portion of VP4. Based on sequence analysis, the putative cleavage sites were located at 
amino acid sites 241 and 246 (Fig 12). Additional minor band 8a was also detected 
which is possibly generated by cleavage at amino acid residue 231 which is a putative 
cleavage site in VP4 of VMRI strain BRV (Mummidi et al. 1995). These results are 
supported by the predicted amino acid sequences of VMRI VP4 and partial amino acid 
Fig. 10. Indirect immunofluorescent antibody test to detect bovine rotavirus antigen in 
insect cells infected with recombinant baculovirus Bac.pBA'Pl (panel 2), Bac.pVLA'P4 
(panel 4), Bac.pVLA'T'6 (panel 6), Bac.pVLA'PT (panel 7), wild type baculovirus 
AcMNPV (W) or insect cell control (H). strain of BRV in MA-104 cell (V) or Ma-
104 cell control (M) were also tested by IFA. Anti-bovine rotavirus polyvalent guinea pig 
sera and FITC labeled anti-guinea pig Igs were used to stain for rotavirus proteins. 

Fig. 11. Radioimmunoprecipitarion of ^^S-labeled proteins in cell lysates of insect cells 
infected with wild type baculovirus (lane W) or recombinant baculovirus Bac.pBA^2 (lane 
2), Bac.pVLAT'4 (lane 4), Bac.pVLA^6 G^ne 6), or Bac.pVLAT? (lane 7) with anriseum 
to rotavirus. Recombinant baciUoviruses were labeled with 200 |iCi of 35$-
methionine/cysteine for 2 hours at 72 hour post infection. Rotavirus specific recombinant 
proteins were precipitated with hyperimmune serum to VMRI strain of bovine rotavirus and 
electrophoresed. All recombinant proteins detected in insect cells infected with recombinant 
baculovirus were similar to that of original rotavirus proteins. 
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Fig. 11. (Continued). 
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Fig. 12. Partial amino acid sequence of VMRI VP4 showing location of putative 
proteolytic cleavage sites at amino acid residues 241 and 246 in VMRI strain of rotavirus 
(bold). In VP4 of VMRI strain there is one additional arginine at amino acid residue 247 
(italic) and an extra putative cleavage site at amino acid residue 23 l(bold and italic). 
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sequences which correspond to this region as shown in Fig. 11-R4. Recombinant 
protein VP6 had a molecular mass of 60 kDa similar to that of the prototype bovine 
rotavirus VP6 and was the most abundant protein expressed in the insect cell system 
(Fig. 11-R6). The recombinant protein VP7 showed a heavy precipitate of a diffuse 
band of approximately 37 kDa in size. This diffuse band indicates that the recombinant 
protein expressed in insect cells is glycosylated (Fig. 11-R7). Details of these results are 
described in a later section. 
Kinetics of recombinant protein expression 
To determine the kinetics of recombinant protein expression, insect cells were 
infected with recombinant baculovirus and proteins in cell lysates were 
immunoprecipitated with anti-VMRI hyperimmune serum at 24,48,72 and 96 hours 
post infection. At 96 hours, because of extensive CPE, there were not enough cells 
remaining for RIP, therefore data was not reliable at this time point. Radioactivity in 
rotavirus specific bands was counted and values are shown in Fig. 13. These results 
indicate recombinant protein expression was highest at 72 hours post infection, and 
declined at 96 hours post infection possibly due to the extensive CPE in recombinant 
virus infected insect cells (Fig. 13). The recombinant protein expression in insect cells 
infected with Bac.pB/VP2, Bac.pVLA'P4, Bac.pVLA'P6, and Bac.pVLA'^P7 infected 
insect cells was highest at 72 hours post infection (Fig. 13). 
Antigenicity of recombinant proteins for guinea pigs 
Immune response of guinea pigs to recombinant proteins was determined by 
the indirect immunofluorescence and virus neutralization tests. Weak immune response 
was detected by indirect immunofluorescence at 3 weeks after the first immunization. 
Fig. 13. Kinetics of recombinant protein expression in insect cell were determined by 
radioimmunoprecipitation. [nsect cells were infected with recombinant viruses 
Bac.pBA^2, Bac.pVLA'^P4, Bac.pVLAT^6, or Bac.pVLAT'7. Proteins were labeled with 
35s-methionine/cysteine and immunprecipitated with hyper-immune serum to VMRI strain 
of bovine rotavirus and eiectrophoresed. Rotavirus specific bands were cut from the gel by 
superimposing X-ray film on the dried gel. Radioactivity in each band was counted in a 
liquid scintillation counter. Mean values of radioactivity was plotted against time. 
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Serum from animals immunized with Bac.pBAT2. Bac.pVLA'T4, and Bac.pVL/VP7 
had dters of 20. The antibody titer to Bac.p VLA'^P6 was higher than the others (1:320 -
1:640). In contrast, serum antibody titers of guinea pigs immunized with the V^IRI 
strain of BRV was 1:40 - 1:80. Guinea pigs immunized with the wild type baculovirus 
AcMNPV remained seronegative. Antibody titers increased following the booster 
injection. The IFA titers in these animals were 1:640 - 1:1280,1:2560 - 1:5120. 1:1280 
- 1:2560. 1:640 - 1:1280, 1:640 - 1:1280 for Bac.pBAT'2, Bac.pVLAT4. 
Bac.pVLA'P6, Bac.pVLAT"?, and BRV VMRI, respectively. Guinea pigs inoculated 
with wild type baculovirus remained seronegative (Fig. 14). Serum samples were also 
tested for rotavirus specific neutralization antibodies. E^reimmune serum samples were 
negative for neutralization antibodies. The virus neutralization antibodies were detected 
in serum of animals immunized with recombinant baculovirus Bac.pVLA'P4. 
Bac.pVLA'PV, or VMRI strain of BRV immunized animals. Virus neutralization titers 
ranged from 1:4 - 1:16 at 3 weeks after immunization. Sera from guinea pigs inoculated 
with Bac. pBAT'2, Bac.pVLA^6, or wild type baculovirus were negative for virus 
neutralization antibodies at 3 weeks after the first immunization. Virus neutralization 
titers increased 3 weeks after booster injection and ranged from 64 to 128 in guinea pigs 
immunized with Bac.pVL/VP4. Bac.pVL/VP7. Titers in guinea pigs immunized with 
VMRI strain of BRV ranged from 32 to 128. Low titers of virus neutralization activity 
was also detected in animals immunized with Bac.p VLAT6. Three weeks after the 
second immunization guinea pigs immunized with recombinant baculovirus Bac.pBA'^P2 
and wild type baculovirus AcMNPV remained seronegative (Fig. 15). The statistical 
analysis of the data by Duncan's multiple range test showed that the virus neutralization 
titers of guinea pigs immunized with recombinant baculovirus Bac.pVLA'P4, 
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Fig. 14. Indirect immunoflorescent antibody titers of serum samples 
from guinea pigs immunized with recombinant baculovirus. Guinea 
pigs were given booster injection at 3 weeks after the initial 
immunization. The blood samples were collected before immunization 
and at 3 and 6 weeks post injection. The data were analyzed using 
one-way ANOVA with repeated measures. P<0.0001 
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Fig. 15. Virus neutralization titers of serum samples firom guinea pigs 
immunized with recombinant baculovirus, VMRI strain of bovine rotavirus 
or wild type baculovirus are plotted vs time (weeks) after initial 
immunization. Two hundred FFU of bovine rotavirus was mLxed with 
serum samples and incubated for 60 minutes. Unneutralized virus was 
titrated in MA-104 cells. The data were analyzed using one-way ANOVA 
with repeated measures. P<0.0001 
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Bac.pVL/VP7. and the VMRI strain of BRV were significantiy different from those 
immunized with Bac.pBA'P2, Bac.pVLA'P6. or AcMNPV (P<0.05). 
VLP fomation 
Insect cells were infected with recombinant baculovirus and cultures were 
examined for virus-like panicles. Infection with recombinant baculovirus Bac.pBA'^P2 
generated sub-core like particles (Fig. 16). The size of these subcore particles ranged 
from 35- 45 nm in diameter. Rotavirus-like particles without cores were formed in cells 
infected with the four recombinant viruses Bac.pBAT2, Bac.pVLA'^P4, Bac.pVLA^P6. 
and Bac.pVLA^7 (Fig. 16). The VLPs shown in these figures were purified and 
incubated with anti-VMRI hyperimmune serum followed by negative staining and 
examined under electron microscope. These empty particles were similar to the rotavirus 
particles purified from a tissue culture grown VMRI strain of BRV (Fig. 16). A long 
tubular structure approximately 70 nm in diameter was also observed (Fig. 16). VLPs or 
tubular structures were not detected in cells infected with recombinant viruses 
Bac.pVLAT'4, and Bac.pVLA^. This indicates that for a VLP formation, recombinant 
proteins expressed from Bac.pB/'VP2, and Bac.pVLA'P6 need to be included. The size 
of the VLPs was 70-75 nm in diameter which is similar to the rotavirus particle. The 
inside diameter of an empty virus-like particle was 42-46 nm which was equivalent to 
that of the sub-core particles (Fig. 16). The empty hollow structure was icosahedral in 
shape. 
Inhibition of receptor binding by recombinant proteins 
To identify the receptor binding protein(s) of the rotavirus, lysates of insect cells 
infected with recombinant baculovirus were incubated with MA-104 cells followed by 
Fig. 16. Electronmicrographs of rotavirus propagated in mammalian cells MA-104 (A), 
virus-like particles (VLP) observed in insect cells infected with recombinant baculovinis 
Bac.pB/VP2 (B), and cells co-infected with recombinant baculovinis Bac.pBAT2, 
Bac.pVLA'P^-, Bac.pVLA^6 and Bac.pVLA'^P? with sizes approximaely 70-75 nm in 
diameter (C and D). A tubular structure was also observed and the diameter of tubular 
structure was similar to the size of VLPs (C). The inside diameter of empty VLPs with 
icosahedral symmetry was 42-46 nm in diameter (D). 

Fig. 16. (Continued). 
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Fig. 16. (Continued). 
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Table 3. Rotavirus receptor blocking assay in MA-104 cells by using recombinant 
viruses. 
Recombinant Baculovirus Number of Foci Percentage of Blocidng (%) 
Bac.pB/VP2 77 23 
Bac.pVLA'P4 II 89 
Bac.pVL/VP6 79 21 
Bac.pVLA^ J 97 
Bac.pBA'P2+Bac.pVL/6 85 15 
Bac.pVLAT4+Bac.pVLA^7 7 93 
Bac.pBA'P24-Bac.pVL/VP4+Bac.p 
VIWP6 
14 86 
Bac.pBAT2+Bac.pVLAT6+Bac.p 
VL/VP7 
9 91 
VP2+Bac.pVLA^4+Bac.pVL/VP6 
+Bac.pVL/VP7 
7 93 
VLPs@ 2 98 
AcMNPV^ 70 30 
BTI-TN-5BI-42 85 15 
None 100 0 
MA-104 cells were preincubated with recombinant baculovirus cell lysates for 2 hours at 
37°C then 100 FFU of VMRI strain of BRV was added and cells incubated for 18 hours. 
Number of fluorescent foci were counted after indirect immunofluorescent staining using 
guinea pig anti-VMRI antiserum and ETTC-labeled anti-guinea pig IgG. Numbers 
represent arithmatic means of foci counted from each treatmenL 
+: recombinant viruses co-infected into insect ceils. 
Virus-like particles. 
I; wild type baculovirus. 
2: Trichoplitsia ni egg cell homogenates cell line. 
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Table 4. Effect of trypsin treatment of recombinant proteins on blocking of rotavirus 
binding to MA-104 cells. 
Recombinant Baculovirus Number of Foci Pecentage of Blocking (%) 
Bac.pVLA'P4 11 89 
Bac.pVL/VP4+Bac.pVLAT7 12 88 
Bac.pBA'P2+Bac.pVLA'P4+Bac.p 
VIVVP6 
12 88 
B ac.p B A^2+Bac.p VL AT4+B ac. p 
VLAa'6+Bac.pVL/VP7 
10 90 
AcMNPVl 70 30 
BTI-TN-5B1-42 85 15 
None 100 0 
Recombinant protein VP4 individually or in combination with other proteins was treated 
with 10 tig/nnl of type IX trypsin (Sigma, St. Louis, MO) at 2)TC for 60 minutes. MA-
104 cells were preincubated with trypsin created recombinant protein(s) followed by 
infecrion with 100 FTU of VMRI strain of BRV. Number of fluorescent foci were 
counted after indirect immunofluorescent staining using guinea pig anri-VMRl antiserum 
and nTC-labeled anti-guinea pig IgG. 
+: recombinant viruses co-infected into insect cells. 
1: wild type baculovirus. 
2; Tiichoplusia ni egg cell homogenates cell line. 
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Fig. 17. Blocking of rotavirus receptors in MA-104 cells using recombinant 
proteins expressed in baculovirus. Recombinant virus Bac.pVLA'^P4, 
Bac.pVLA^, and wild type baculovirus AcMNPV were used to block 
rotavirus receptors in MA-104 cells followed by infection with 100 fTU of 
VMRI strain of BRV. Rotavirus specific fluorescent foci were counted 
by IFA at 20 hours after rotavirus infection. 
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addition of 100 FFU of rotavirus. The ability of recombinant proteins to block binding 
of rotavirus to MA-104 cells was measured. As shown in Table 3. baculovirus 
expressed rotavirus proteins VP4 and VP7 independendy blocked infection of MA-104 
cells with the VMRI strain of BRV. But VP2 and VP6 did not inhibit the rotavirus 
infection of MA-104 cells (Table 3). As shown in table 4. trypsin treatment did not effect 
the blocking of receptors by recombinant proteins in MA-104 cells. Recombinant 
baculoviruses Bac.pVL/VP4 and Bac.pVLA^V with titer of 10^-0 TCID50/ml were able 
to block greater than 90% of rotavirus receptors in 10^ cells/ml of MA-104 cells (Fig. 
17). The numbers representing fluorescent foci from WO FFU of VMRI strain of BRV 
infected MA-104 cells. Purified VLPs most effectively blocked rotavirus receptors on 
MA-104 cells. VLPs concentrated one hundred times from supernatant containing 
recombinant baculovirus at approximately lO*^-^ ETU/ml were diluted 10 fold and added 
to MA-104 cell (10^-^ cells/ml). The saturation point was found to be 10^-^ FFU/ml for 
lO^-O cells/ml (Fig. 17). A thousand fold diluted VLPs were able to block about 509c of 
the rotavirus receptors in MA-104 cells. These results indicate that MA-104 cells have as 
many as 103 - 103-5 receptors per cell. Cell lysate prepared from insect cells infected 
with recombinant baculovirus singly or in combination did not influence virus blocking 
on MA-104 cells (Table 3). Results of blocking of virus infectivity on MA-104 cells 
with recombinant baculovirus cell lysates or purified virus-like particles were similar. 
Discussion 
Recombinant rotavirus proteins VP2, VP4. VP6 and VP7 were successfully 
expressed in baculovirus expression system. We were able to detect rotavirus specific 
antigens in ceUs infected with recombinant baculovims containing these genes by indirect 
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immunofluorescence and radioimmunoprecipitation. Reactivity of antisera was specific 
to rotavirus as the antisera to rotavirus did not react with uninfected cells or cells infected 
with wild type baculovirus. Similarly, preimmune sera also did not react with insect cells 
infected with recombinant baculoviruses. Characterization of these recombinant proteins 
by radioimmunoprecipitation further showed that VP2. VP4. VP6 and VP7 were 
successfully expressed in insect cells. 
Recombinant proteins expressed in the baculovirus system appeared authentic 
and were similar to that of rotavirus proteins. The molecular mass of recombinant 
protein VP2 expressed in insect cells was approximately 102 kDa which is similar to that 
of the VP2 protein in group A rotavirus (Mattion et al., 1994). A slower nriigrating weak 
band was detected by RIP widi lysates of cells infected with Bac.pB/VP2. This band 
possibly represents a heavy glycosylation product which is common in baculovirus 
expressed proteins. Sequence analysis shows that there are two potential N-
glycosylation sites at amino acid residues 590 and 845 in VP2 of the bovine rotavirus 
(Tianetal., 1990). 
The molecular mass of 88 kDa of recombinant protein VP4 was also similar to 
that observed in rotavirus (Mattion et al., 1994) and it was the most abundant 
proteindeiected, although three minor bands were also observed. There were three minor 
bands observed by RJDP in insect cells infected with recombinant baculovirus 
Bac.pVL/VP4. The two bands with Mr. of 60 and 28 kDa which are possibly represent 
VP5 and VPS. The VP8 has shown to possess an hemagglutinin epitope in rotavirus 
(Fiore et al., 1991). The VP5* is a 60 kDa protein which is located on the carboxy 
terminal side of VP4 (Mattion et al., 1994). The third minor band degignated VP8a, is 
possibly generated due to the presence of an additional trypsin cleavage site found at 
amino acid residue 231 in the VMRI strain of BRV. This study that the predicted trypsin 
I l l  
cleavage site at amino acid residue 231 may be active. The abundance of VP4 protein 
expressed in insect cells was unexpected as in previous RIP studies of rotavirus grown in 
mammalian cells (Estes, 1990). In this study, the baculovirus expressed recombinant 
VP4 protein showed very clearly an advantage in protein expression over the mammalian 
cell system. Using the recombinant protein expression in insect cells, we have 
successfully demonstrated that the arginine at aa 231 of the VP4 is an active cleavage site 
for cellular proteolj^c enzymes and insect cells have the ability to process recombinant 
rotavirus protein in the same manner as mammalian cells. An additional putative 
proteolytic enzyme cleavage site at aa 231 found in the VP4 gene sequence was 
confirmed as a proteolytic enzyme cleavage site. 
The molecular mass of 45 kDa recombinant protein VP6 was also similar to 
that in rotavirus and propagated in mammalian (Mattion et al., 1994). It was the most 
abundantiy expressed protein amongst VP2, VP4, VP6 and VP7 in insect cells (data not 
shown). The mechanism for higher expression of recombinant protein VP6 over die 
other rotavirus genes in the insect cell system is not understood. The VP6 protein is also 
the most abundant viral protein in die rotavirus virion which is composed of over 60% of 
viral proteins. 
The recombinant VP7 also appeared authentic as its molecular mass was 38 
kDa which is similar to that of native rotavirus protein. The recombinant protein VP7 
shown in Fig. 11 indicates that the protein expressed in baculovirus is post translationally 
modified and shows the advantage of the eukaryotic expression system over prokaryotic 
expression. Based on similarity in molecular mass and glycosylation in VP7, we expect 
that the recombinant VP7 will have biological activities similar to that of VP7. 
fCinetic studies of recombinant protein expression allowed us to estimate an 
optimal time point for harvesting recombinant virus to get a maximum yield of 
112 
recombinant proteins. In addition, this study provide information on secretion of 
recombinant protein into the culture medium from recombinant vims infected cells. 
Previous reports indicate that the expression of rotavirus recombinant proteins in insect 
cells peaked at 48 hours after infection and low yields of VP7 protein expression was 
attributed to the secretion of the protein into the culture media (Redmond et al., 1993). 
They also reported that VP7 protein expression peaked at 24 hours post infection in Sf9 
cells and 96 hours post infection in the supernatant of the recombinant virus infected 
insect cells. But in this study the highest expression of recombinant protein VP7 was at 
72 hours after infection in Hi-Five cells. Recombinant proteins were not secreted into the 
culture medium from any of recombinant viruses during die early stage of infection. We 
were able to detect recombinant proteins in medium during the late stages of infection but 
it coincided with extensive CPE in the recombinant virus infected insect cells rather than 
protein secretion into medium. Lack of protein secretion in the medium is common for 
proteins expressed in insect cell system (Wickham et al, 1992) 
Two different types of CPE were observed in recombinant virus infected insect 
cells provided some functional characteristics of rotavirus proteins. One type of CPE 
was cell rounding followed by cell lysis and the other type was fusion of the insect cells 
followed by cell lysis. Recombinant baculovirus containing genes. VP4 or VP7 
produced cell fusion. The fusion activity was greatest with recombinant baculovirus 
Bac.pVL/VP4, which suggesting that it is the primary protein responsible for fusion. 
These finding is in agreement with those reported previously (Estes et al., 1989; Mattion 
et al., 1994). The recombinant virus VP7 also showed weak fusion activity in insect 
cells which was unexpected. This activity may indicate that VP7 is a putative cell 
receptor binding protein in mammalian cells. Competition assay confirmed that VP? 
does play a role in rotavirus binding to cells. In a receptor blocking assay using 
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recombinant viruses, both VP4 and VP7 blocked rotavirus infection in MA-104 cells, but 
VP2 and VP6 recombinant viruses did not block infection. But there is no clear evidence 
which protein(s) are responsible for receptor binding. Since only triple layered particles 
are infectious it may be possible that both VP4 and VF7 proteins are responsible for 
receptor binding because these two proteins comprise the outer layer of the virion. 
Current research results indicate that baculovirus expressed viral proteins self 
assemble into virus-like particles and are immunogenic in experimental animals (French 
and Roy, 1990: Luo et al., 1990; Sahara et al., 1991; Loudon and Roy, 1991; Jiang et 
al., 1992; Laurent et al., 1994; Prasad et al., 1994). In this study we have successfully 
produced virus-like particles by using combinations of recombinant viruses expressing 
rotavirus proteins. Single infection of insect cells with Bac.pBA^2 produced sub-core 
particles and the size of these particles was similar to that of BRV subcores as reported 
previously (Labbe et al., 1991; Zeng et al., 1994). Co-infection of insect cells with 
recombinant viruses Bac.pBA^2, Bac.pVLA^4, Bac.pVLAT^6, and Bac.pVL/VP7 
formed rotavirus like particles, without the core structures containing VPl. VP3 and 
segments of rotavirus nucleic acid. Morphology and size of the empty particles was 
similar to that of rotavirus particles purified from a tissue culture grown VMRI strain of 
BRV. Similar results with rotavirus capsid proteins expressed in insect cells has been 
reported (Crawford et al., 1994). Additionally the tubular structures have been observed 
in insect cells infected with recombinant baculoviruses. Recombinant viruses containing 
VP4 and VP7 genes singly or in combination did not form any VLPs or tubular 
structures. This indicates that VP2 and VP6 are required for VLP formation. The size of 
VLPs was 70-75 nm in diameter which is similar to the rotavirus particles purified from 
mammalian cell cultures or virus samples processed from fecal materials (Prasad et al., 
1988; Yeager et al., 1990). The empty center holes were 42-46 nm in diameter which is 
114 
equivalent to core particles. Icosahedral symmetry of the empty hollow structures 
indicate that protein assembly in baculovinis expressed recombinant protein is similar to 
the rotavirus assembly process in mammalian cells and infeaed animals. This protein 
expression technology is useful for investigating viral protein assembly in individual 
protein levels and will provide detailed information on virus replication at the assembly 
stage, and on the requirement of viral proteins for this process. 
Immune response to a recombinant virus in experimental animals is an 
important step for the evaluation of potential application to animals as a preventive 
vaccine. Authenticity of recombinant protein, and the amount of recombinant proteins 
expressed in an insect system affect the immune response. The recombinant proteins 
expressed in baculovirus were immunogenic in guinea pigs. The immune response was 
specific to rotavirus as guinea pigs immunized with wild type baculovirus were 
seronegative. Evaluation of sera by virus neutralization test showed that VP4 and VP7 
contain the major neutralization epitopes as only not VP2 induced VN antibodies. Abilit\' 
of VP4 and VP7 proteins to elicit high level of rotavirus specific virus neutralization 
antibodies has been controversial. Nishikawa et al. (1989) were able to induce 
neutralization antibodies with baculovirus expressed VP4 protein, however Redmond et 
al. (1993) were unable to induce neutralization antibodies in animals with recombinant 
baculovirus containing VP7. The reason for this discrepancy is not clear. Similarly 
inconsistent results were obtained with recombinant proteins expressed in a prokaryotic 
system. Recombinant protein expressed in prokaryotic system did not induce any 
neutralization antibodies whereas in another smdy neutralization antibodies were induced( 
Arias etal. 1986; Francavilla et al. 1987). 
In addition to VP4 and VP7, VP6 also induced neutralizing antibodies 
although titers induced with recombinant VP6 were low. This observation was 
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surprising and new. The VP6 has shown to provide partial protection in mice. 
(Redmond et al.. 1993). The results of this study show that ability of recombinant VP6 
to induce neutralizing antibody provide in part explanation of protection observed by 
Redmond et al. (1993). 
There has been a controversy as to which rotavirus protein is responsible for 
binding to culture cells. Both VP4 and an outer capsid glycoprotein have been proposed 
to play a role in binding to receptors on rotavirus susceptible cells (Sahara et al.. 1985; 
Ruggeri and Greenberg. 1991). In another study (Bass et al., 1990) a nonstructural 
rotavirus protein suggested as the major protein responsible for binding to target cells 
(Bass et al., 1990). Because of the controversy surrounding the role of different proteins 
in binding with the receptor, we examined the role of recombinant VP4 and VP7 in cells. 
Our results indicate that VP4 and VP7 proteins are important for the cell binding. In this 
study, we have clearly shown that both VP4 and VP7 are the major proteins responsible 
for binding to MA-104 cells. Baculovirus expressed recombinant rotavirus proteins VP4 
and VP7 independendy blocked target binding of the VMRI strain of BRV to MA-104 
cells, resulting in no virus infection in the cells. The virus neutralization test results also 
support this hypothesis (Table 16). Resistence of receptor binding activity to trypsin 
treatment as observed by Kaljot et al. (1988) further supported our results that VP4 and 
VP7 are the major proteins responsible for virus binding to cells. The number of 
rotavirus receptors on MA-104 cells was shown to be 10^-10^-^ receptors per cells for 
the VMRI strain of BRV. This estimate is lower than that of 10^-^/cell reported by 
Kaljot (1990). This difference in results may be due to the different passage level of 
susceptible cells and/or the different strain and passage levels of rotavirus. 
This study has shown that recombinant proteins expressed in insect cells using 
baculovirus expression system are similar to that of native rotavirus proteins and have 
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potential as vaccine for rotavirus gastroenteritis. This technology has special role in 
understanding functional characteristics of rotavirus proteins and development of vaccine 
for noncultivable rotavirus. 
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INCREASED EXPRESSION OF BOVINE ROTAVIRUS PROTEIN VP7 IN INSECT 
CELLS BY REMOVAL OF TERMINAL NONCODING SEQUENCES 
A paper to be submitted to the Journal of General Virology 
Young S. Lyoo and Prem S. Paul 
Abstract 
The glycosylated capsid protein. VP7, of rotavirus has previously been expressed 
in eukaryoric and prokaryodc expression systems including insect cells using baculovirus 
as a vector, however, expression levels have been poor. To increase the expression of 
VP7. we have investigated the effect of removing terminal non-coding sequences, 
upstream and downstream of the VP7 open reading frame (ORF). on its expression in 
insect cells. The VP7 gene from the VMRl strain of bovine rotavirus was amplified by 
polymerase chain reaction and cloned. Four constructs were generated in a baculovirus 
transfer vector pVL1393 to be expressed as nonfusion proteins under the control of a 
baculovirus polyhedrin promoter. The construct pVL/VT7.A contained a full sequence 
of the bovine rotavirus VMRl VP7 gene including the noncoding sequences, constmct 
pVLA'^PT.B contained the VP7 gene in which the noncoding region at 3' end was 
deleted, construct pVLATT.C was composed of the VP7 gene in which the 5' noncoding 
sequence was deleted, and construct pVLATT.D bears the VP7 gene in which noncoding 
sequences upstream and downstream of the VP7 open reading frame were deleted. 
Recombinant DNA from these four constructs was used to generate recombinant 
baculovirus and the expression of VP7 with each recombinant baculovirus was 
evaluated. Rotavirus VP? mRNA was detected in insect cells infected with any of the 
four recombinant baculoviruses. Insect cells infected with recombinant baculovirus 
Bac.pVLA'PT.D had the highest amount of transcriptional activity. Level of protein 
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expression by radioimmunoprecipitation was highest with recombinant baculovirus 
Bac.pVLAT7.D and was at least ten fold more than that with the other three recombinant 
baculoviruses. These results show that removal of non-coding sequences at both the 5' 
and 3' ends increased expression of recombinant protein in this system and expressed 
protein appeared audiendc as the molecular mass and modification of proteins appeared 
similar to that of rotavirus. 
Introduction 
Rotavirus belongs to the genus rotavirus in the family Reoviridae and is an 
important pathogen of gastroenteritis in infants, young children and animals (Estes et al. 
1983: Paul and Lyoo, 1993). Rotavirus particles are non-enveloped, triple-layered 
(previously called double-shelled capsid) and measure approximately 75 nm in diameter 
(Estes and Cohen, 1989; Zeng et al. 1994). Recent evidence based on high resolution 
cryoelectron microscopy (Prasad et al. 1988; Anthony et al. 1991) suggests that rotavirus 
particles have 60 surface spikes, about 10 nm long with a globular end structure, in the 
outer capsid. Viral cores contain the viral transcriptase and a genome consisting of 11 
segments of double stranded RNA. Each RNA segment starLs with a 5' guanidine 
followed by conserved sequences that are part of the 5' non-coding translational 
sequences, an open reading frame coding for each protein product, and another set of 3' 
non-coding sequences which end with a 3'-terminal cytosine (Estes and Cohen, 1989). 
Rotaviruses have two major surface proteins, VP4 and VP7. which are believed 
to be the major immunogens of rotavirus (Matsui et al. 1990; Paul and Lyoo, 1993) as 
both induce neutralization antibodies, and are believed to be important in providing 
protection. Because of their role in neutralization, both VP4 and VP7 have been used to 
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type rotaviruses. Rotavirus types based on a protease sensitive protein, VP4, have been 
designated as P types, whereas types based on glycoprotein VP7 have been referred to as 
G types. The VP7 is the major neutralization glycoprotein which plays an important role 
in serotype specific virus neutralization and cell attachment (Greenberg et al. 1983; 
Hoshino et al. 1985; Sahara et al. 1985; Blackball et al. 1992). The VP7 protein was 
clearly demonstrated as the dominant immunogen among the rotavirus proteins in infants 
using bovine rotavirus as a vaccine and in experimental animals inoculated with 
inactivated rotavirus (Ward et al. 1990). VP7 is glycosylated with a high concentration 
of mannose and is comprised of 326 amino acids. .After cleavage of the signal peptide, 
the mature cleaved protein contains 276 amino acids with a molecular mass of 38 IcDa. 
Nucleotide sequence analysis has identified six regions on VP7 which are highly 
conserved among different rotavirus strains of the same serotype, but are divergent 
among different serotypes (Pedly et al. 1983; Glass et al. 1985; Green et al. 1987). 
Three of these regions encode for neutralization epitopes A, B and C as shown by studies 
using escape mutants. Region A is located at amino acid residues 87-101, region B at 
amino acid residues 145-152, and region C is located at amino acid residues 211-223 
(Dyall-Smith et al, 1986). Using recombinant VP7 protein and a synthetic peptide (aa 
275-295), VP7 has been shown to produce neutralization antibodies and provide passive 
protection in mice against rotavirus infection (Matsui et al. 1989). Passive immunity in 
calves is considered to be very important in protection against rotavirus infection 
(Snodgrass, 1982). Recombinant VP7 offers a potentially effective vaccine for rotavirus 
associated gastroenteritis in calves. 
In a preliminary study, we attempted expression of VP7 of a bovine rotavirus in 
insect cells, using the baculovirus expression system. We were successful in its 
expression, however expression was poor. Therefore, in order to increase VP7 
127 
expression the effect of removal of noncoding sequences was examined. Our results 
show that expression of VP7 is increased following removal of noncoding sequences. 
The expressed recombinant protein appears to be authentic as it is glycosylated, and has a 
molecular mass similar to that of native VP7, it also reacts with antisera to bovine 
rotavirus. 
.Materials and Methods 
V[n<s and cells 
The VMRl strain of bovine rotavirus with a super-short electrophoretic pattern 
(Paul et al. 1988; Matsui et al. 1990) was used as a parent virus for this experiment 
This strain has a P5 and a G6 type. The plaque purified virus was propagated on 
monolayers of monkey kidney cells (MA-104) in the presence of 0.5 |J.g/ml of crystal 
trypsin (Type EX, Sigma St. Louis, MO) to improve virus replication. The MA-104 cells 
were washed three times with serum free Dullbeco's minimal essential medium (DMEM, 
Gibco-BRL, Gaithersburg, MD) and inoculated with the VMRl strain of bovine rotavirus 
at a multiplicity of infection (MOI) of 0.1. The virus-inoculated MA-104 cells were 
incubated at 37 C in a CO2 incubator for 60 minutes with occasional rocking to increase 
the virus infection. After a 60 nrunute incubation, the viral inoculum was removed and 
the cells were washed once with serum free DMEM to remove residual viral inoculum, 
then fresh DMEM containing 0.5 [ig/ml of trypsin as maintenance media was added. The 
9 
cells were incubated for three days in a CO2 incubator at 37 C. The infected cell cultures 
were frozen and thawed three times, and the virus was then pelleted by high speed 
centrifugation for 90 minutes at 100,000 Xg. The viral pellet was extracted in 1,1,2-
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Trichloro-l,2,2-trifIuoroethane (Genetron. Johnson Matthey Electronics. MA) and virus 
in the aqueous phase was collected after low speed centrifugacion for 20 minutes at 3000 
rpm. To pellet virus particles, supernatant was centrifuged for 90 minutes at 25,000 rpm 
and the pellets were resuspended in 500 [il of sterile deionized water. The resuspended 
sample was layered on a continuous cesium chloride density gradient (1.2 - 1.4 mg/ml) 
for further purification. After a 4 hour centrifiigation, die virus bands were collected and 
their density was measured and dialyzed against PBS at 4 C ovemighL An aseptically 
collected dialyzed virus sample was treated with EDTA at a final concentration of 50 mM 
for 2 hour at 37 C and core particles were pelleted through a 30% sucrose cushion at 
25.000 rpm for 60 minutes. The peUet was resuspended with 100 |il of sterile water and 
o 
stored at -80 C for the in via'o transcription of viral mRNA . 
In vin-o mRNA vanscripnon and first svand cDNA synthesis 
The viral mRNA was transcribed in vin-o by using virus containing RNA 
dependent RNA polymerase from purified rotavirus core particles as described 
previously (Flores et al. 1982). The reaction mixtures were prepared in 2X transcription 
buffer (100 mM of Tris-HCl, 0.5 mM of NaOAC, 30 mM of MgOAc, pH 8.0) 
containing ATP (8 mM), CTP (2.5 mM), OTP (2.5 mM). UTP (2.5 mM). S-adenosyl-
methionine (0.5 mM), RNase inhibitor, and the purified viral cores. The reaction 
o 
mixture was incubated for 6 hours at 42 C and newly synthesized mRNA was 
precipitated with lithium chloride. The first strand cDNA was synthesized with a cDNA 
cycle kit (Invitrogen, San Diego, CA) using mRNA as a template. VP7 gene specific 
primers and avian myeloblastosis virus (AMV) reverse transcriptase (Invitrogen, San 
Diego, CA). After completion of the cDNA synthesis the final product was extracted 
with phenol/chloroform, concentrated by ethanol precipitation and redissolved in 10 mM 
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Tris-HCl buffer (I miM EDTA, pH 8.0). The first strand cDNA was used as a template 
for PCR amplification of the bovine rotavirus VP7 gene and construction of vectors for 
expression. 
PCR amplification of bovine rotavirus genes 
For the amplification of the full length VMRIVP7 gene, or the VP7 gene without 
part or all of the non-coding sequences, primers were designed based on the VP7 gene 
sequence of bovine rotavirus strain VTvtRI (Fig.I). Restriction endonuclease cleavage 
sites and additional guanidines were added to facilitate the construction of the transfer 
vector and for protection of the restriction sites. Primers used in this experiment were 
PI as a 5' terminal primer (GGG GATCC G GCT TTA AAA GAG AGA ATT T), P2 
as a 5' internal primer with tataaat sequence (GGGGGA TCC tataaatAJ G TA TGG TAT 
TGA A), P3 as a 3' terminal primer (GGC AAT TC G GTC ACA TCA TAG TAA 
TCC), and P4 as a 3' internal primer (GGG AAT TC T TAT TTG ATT GAC GTA ATC 
C). These primers were used for the amplification of full or part of die genome without 
the non-coding regions in a PCR reaction. Briefly, the VP? gene of bovme rotavirus 
isolate VMRI was amplified using first strand cDNA as a template in a PCR reaction with 
Taq-1 DNA polymerase (Invitrogen, San Diego, CA), and various sets of primers. 
Reaction mLxtures containing cDNA template. dNTPs (0.2 nuVI/each, Pharmacia), 
primers (2 fiM), MgCll (3 miVI, Pharmacia) and lOX reaction buffer (Invitrogen. San 
Diego, CA) were prepared in an ultraviolet light sterilized vertical laminar tlow hood to 
prevent nonspecific DNA amplification from contamination. The reaction mixture was 
overlaid with 50 jil of mineral oil to prevent evaporation during the PCR reaction. PCR 
amplification was conducted in a thermocycler (Coy, iVII). The first cycle consisted of 90 
o 0 
seconds for denaturation at 94 C, 2 minutes for annealing at 48 C and 5 minutes for 
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extension at 11 Q. It was then followed by 30 cycles of amplification with denaturation at 
o o ^ 
94 C for 1 minute, annealing at 48 C for 2 minutes, and primer extension at 72 C for 2 
minutes. During the last cycle, the extension time was changed to 10 minutes while the 
other conditions remained the same. The amplification products were analyzed by 
elctrophoresis in a 1% agarose gel (FMC Bioproducts, Rockland, ME) followed by 
ethidium bromide staining. A DNA band of 1.06 kb was observed for the full length 
VP7 gene with other bands migrating slighdy faster than 1.06 kb. The DNA samples 
were purified using a sephacyl column (Boehringer Mannheim Biochemicals. 
Indianapolis, IN) and purified DNAs were used for cloning and sequencing experiments. 
Molecular cloning and construction of baculovirus vansfer vectors 
To determine the nucleotide sequence of the VP7 gene, PCR-amplified double 
stranded cDNA was cloned in an £. coll phagemid vector. A full length VMRl VP7 
gene was inserted into phagemid vector pKS"*". After transformation into DH5 a cells, 
white colonies were selected on agar plates in the presence of ampicillin, X-gal and 
IPTG. The nucleotide sequence was determined by the Sanger dideoxy chain termination 
method (Hindley, 1983) using an automated DNA sequencer (Applied Biosystem, Foster 
city, CA). Three clones were sequenced (Mummidi et al. 1995, submitted for 
publication). The sequence was analyzed and translated into amino acids using a 
computer program (Geneworks, Intelli Generics Inc., Mountain View, CA) 
To construct baculovirus transfer vectors, PGR amplified DNA samples were 
digested with BamHI and EcoRI and purified by using a CL-4B sephacyl column 
(Boehringer Mannheim, Indianapolis, EN., size exclusion >271 base pair). The 
baculovirus transfer vector pVLI393 (Invitrogen, San Diego. CA) was digested with 
BamHI and EcoRl, and purified by using a CL-4B sephacyl column for the ligation 
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using T4 ligase. Tubes containing the ligation mixture were incubated at 5 C overnight 
and transformed into competent ceils of E. coli strain DH5a. Colonies of E. coli 
containing recombinant plasmids were analyzed for the presence of inserts by restriction 
endonuclease digestion with Bam HI and Eco RI of DNA. followed by electrophoresis in 
agarose. Selected colonies were cultured on agar plates and single colonies were 
inoculated into 150 ml of LB broth to prepare the DNA samples for transfection to 
generate recombinant viruses. DNA was purified by passing through Qiagen columns 
(Qiagen, Hilden, Germany) following manufacturer's instructions and quanritated by 
spectrophotometry at 260 nm. Constructs prepared from these ligations were derived 
from PCR products using various primers: construct A with P1 and P2, construct B with 
PI and P3, construct C with P2 and P4, and construct D with P2 and P3 sets of primers. 
The P3 primer was designed upstream of the stop codon and the stop codon was altered 
from TAG to TGA. Therefore, the recombinant protein product is expected to be 11 
amino acids shorter than that of the full length VMRl VP7 gene product 
Production of recombinant baciilovirm by homologous recombination 
The DNA from recombinant baculovirus transfer vector pVL1393 containing the 
VP7 gene and \.vild type baculovirus were used for transfection of insect cells to produce 
recombinant virus. A 50 }il mixnire composed of 50 ng of linearized baculovirus 
AcMNPV DNA and 1.5 jig DNA from different constructs containing VMRl VP7 gene, 
were mixed with 50 |il of lipofectin (Gibco-BRL. Gaithersburg, MD) and incubated at 
room temperature for 15 minutes. Meanwhile, Hi-Five (BTI-TN-5B1-4: Invitrogen, San 
Diego, CA) insect cells were prepared in 6-weIl cell culture plates, at a cell concentration 
of SXlO^/ml. and placed on a flat surface for 60 minutes at 27°C to allow the cells to 
attach to die culture vessel. After 60 minutes of incubation, new insect cell culture 
medium was added and the DNA/ lipofectin mixture was added drop by drop. For 
efficient transfection, cells were left undisturbed in a vertical laminar flow hood for 6 
hours at room temperature. The DNA solution used for transfection was removed by 
aspiration after 6 hours incubation and 3 ml of fresh insect cell culture medium was 
added. Transfected cells were further incubated for 72 hours at 27°C to allow for the 
homologous recombination and replication of recombinant virus. 
Plaque purification of recombinant viruses 
To isolate pure clones, recombinant baculovirus containing the bovine rotavirus 
VMRI VP? gene were plaque purified. The insect cell cultures were harvested at 72 hour 
after transfection and transfected cell cultures were clarified by low speed centrifugation 
at 4 C for 20 minutes at 2,000 rpm and clear supematants were collected in sterile snap 
cap tubes. The supematants were serially diluted 10 fold to inoculate the insect cells. 
Cells were incubated for 60 minutes at room temperature to allow infection of insect cells 
with die recombinant virus. After 60 minutes, the inoculum was removed and 3 ml of 
1.25% agarose in Excell-400 insect cell culture medium was added onto the insect cells. 
After solidification of agarose, 3 ml of insect cell culture medium was added to provide 
enough moisture during further incubation period and cells were incubated for 72 hours 
o 
at 27 C without C02 supply. Occlusion-negative isolated virus plaques were picked 
using sterile Pasteur pipettes and diluted into 0.5 ml of insect cell culture medium. Tubes 
o 
containing recombinant virus were stored at 4 C overnight to release virus particles into 
9 
the media and were then centrifuged at 2,000 rpm for 10 minutes at 4 C. This entire 
purification step was repeated three times to ensure clonal population. After three rounds 
of purification, the supernatant containing recombinant virus was stored at -80 C until 
the next experiment. 
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Detection ofrotaviral genome in recombinant baculovinis infected insect cells by dot 
blot hybridization assay 
Rotavirus cDNA generated by PGR amplification was labeled with 
(ICN Biochemical, Costa Mesa, CA) using a random primer extension method 
(Amersham, Arlington Height, IL) to confirm the presence of rotavirus genes in 
recombinant bacuiovirus. Hi Five cells infected with recombinant baculovirus were 
frozen and thawed once and clarified by low speed centrifugation. The supematants 
were then pelleted at 37,000 rpm for 90 minutes and viral DNA was extracted with 
phenol/chloroform. The aqueous phase was collected and precipitated in ethanol and 
boiled for 5 minutes to denature the nucleic acids. Hi-Five cells infected with wild type 
baculovirus were prepared by the same manner and used as a control. Plasmid vectors 
containing the bovine rotavirus VP? gene were used as positive controls and the pKS"^ 
plasmid itself as a negative control. Denatured nucleic acids were applied on a nylon 
o 
membrane (Zeta probe. Bio-Rad, Hercules, CA) and baked for 2 hours at 80 C to 
immobilize the nucleic acids. For the probe preparation, PCR amplified bovine rotavirus 
VP7 gene was labeled with a^-P-dCTP for 4 hours at room temperature using random 
primers multi-labeling kit (Amersham, Arlington Height, EL). A radio-labeled DN.A. 
probe was passed through Sepharose columns (Boehringher Mannheim, Linkers 6 Quick 
spin column Sepharose CL-6B) and boiled for 5 minutes at 100 C before hybridization. 
o 
The baked membrane was prehybridized for 4 hours at 65 C with a prehybndization 
solution (5X SSC, 5X Denhardt's solution, and salmon testes DNA), and hybridized 
o 
overnight with denatured probes. The hybridization reaction was carried out at 65 C 
without formamide. After hybridization, the membranes were extensively washed with 
washing buffer containing 0.1% SDS solution. First two washes were with 2X SSC, 
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followed by two washes with IX SSC two washes with O.IX SSC and final wash with 
sterile water. The membrane was exposed on X-ray film (Fuji RX film, Japan) for 4 
hours at room temperature prior to developing. 
Detection of rotavirus antigens by immwiofliiorescent test 
Indirect immunofluorescence test was used to detect rotavirus specific 
recombinant proteins in insect cells infected with recombinant baculovirus. The Hi-Five 
cells infected with recombinant or wild type baculovirus or mock infected cells were 
fixed with cold methanol in 24-well cell culture plates at 72 hours after infection and 
examined for viral antigens. An appropriate dilution of guinea pig anti-rotavirus 
polyclonal antibody was added to the fixed cell monolayers and cells were incubated for 
60 minutes at 37 C. The cell monolayers were washed to remove unincorporated 
antibodies. An optimum dilution of fluorescein isothiocyanate labeled anti-guinea pig 
antibodies (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD) were added and 
cells funher incubated for 30 minutes at 37 C. After washing three times with PBS, cells 
on tissue culture plate were examined for fluorescence under the fluorescent micTOscope. 
Detection ofniRNA by dot blot hybridization 
To compare relative transcriptional activity of each construct total mRNA was 
isolated from cells infected with recombinant baculovirus at 28-30 hours after infection. 
RNA samples were isolated by using a total RNA isolation kit (Stratagene, La Jolla. CA) 
from 75 cm- flasks of cells infected with recombinant baculovirus Bac.pVLA^.A. 
Bac.pVLA^P7.B, Bac.pVL/VP7.C, and Bac.pVL/VP7.D containing VP7.A. VP7.B, 
VP7.C and VP7.D construct, respectively, according to manufacturer's instructions. 
Isolated RNAs were denatured by boiling and applied on a nylon membrane. The 
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membrane was baked for 2 hours at 80 C and prehybridized with a prehybridization 
solution (5X SSC, 6X Denhardt's solution, and salmon testes DNA) for 4 hours at 
65 C. The PGR amplified VMRIVP7 gene probe was labeled with ^-P-dCTP and was 
9 
used to hybridize with nucleic acid at 65 C overnight. The membrane was extensively 
washed twice with 2X SSC (0.1% SDS). two times with IX SSC (0.1% SDS). two 
ti.mes with O.lX SSC (0.1% SDS) and once with sterile water. The X-ray film was 
e 
exposed to the membrane overnight at -70 C before developing. To quantitate the 
intensity of the signal in the dots, densitometric analysis employing an image analysis 
system (Zeiss SEM-IPS, Zeiss-Kontron, EBAS version 2.00) was employed. 
Photographs were placed on a copy stand and viewed with reflected light, while films 
were transilluminated using a ChromaPro 45 light box. Images were captured with a 
Kodak XC-77 black and white video camera equipped with a Contax 60 mm macro lens. 
Areas to be measured were determined interactively and the mean gray value for that area 
was also measured. Area and grey values were multiplied to generate real values for each 
dot. Two values from each dot of the samples were calculated to obtain an average value 
for the sample. 
Radioimmunoprecipitation 
Radioimmunoprecipitation was carried out for each different recombinant virus to 
determine molecular mass of recombinant rotavirus proteins in insect cells. The insect 
cells were infected v/ith the recombinant or wUd type baculovirus at a lMOI of 0.1. Two 
days later methionine-free medium (Gibco-BRL, Gaithersburg, MD) was added to cells 
for 2 hours and then ^^S-methionine/cysteine (ICN Biochemicals, Costa Mesa, CA) 
containing medium was added, and labeled for 2 hours at 27 C. The anti-VMRI serum 
was incubated for I hour at room temperature with cold lysates from Hi-Five cells 
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infected with wild-type baculovirus AcMNPV to eliminate antibodies to wild type 
baculovirus and/or insect cells. The cold lysate was prepared from AcMNPV-infected 
Hi-Five cells as follows. The Hi-Five cells in 75 cm- tissue culture flask (Coming, NY) 
o 
were infected with AcMNPV and incubated for 72 hours at 27 C. After removal of 
supernatant from the flask, 2.5 ml of lysis buffer (1% NP40, 150 mM NaCl. 50 mM 
Tris-HCl. 0.5 |ig/ml leupeptin, 100 [ig/ml phenylmethylsulfonylfluoride (PMSF), and 1 
iig/ml pepstatin A, pH 8.0) was added into each flask and placed at room temperature for 
5 minutes. The lysed cells were collected into 1.5 ml microfuge tubes and vonexed for 3 
minutes then incubated for 3 minutes on ice. Cell debris was removed by centrifugation 
0 
for 1 minute in a microcentrifuge and the supernatant was saved as cold lysate at -80 C. 
Radiolabeled (hot) cell lysates were prepared as described above and 50 |il of the cold 
lysate-treated serum was added into 100 |il of hot lysate. The mixture was incubated 
overnight at 4 C to form an immune complex. To capture the immune complex, 100 jil 
of CL-4B bound protein-A (SC.^, Sigma, St. Louis, iMO) was added and rotated for 1 
hour at room temperature. Protein-A-bound immune complexes were washed three times 
with lysis buffer followed by three washes with sterile water. Samples were mixed with 
50 |il of sample loading buffer [4% SDS, 125 rruVI Tris-HCl, pH6.7, 30% glycerol 
(v/v), 0.002% bromphenolblue (w/v); 2% P-mercaptoethanol (v/v)] then boiled for 5 
minutes just before running on a gel. An X-ray film (Fuji RX film, Japan) was exposed 
to the dried gel. The image analysis method used for mRNA quantitation was used to 
quantitate the intensity of the bands except that the rotavirus-specific bands were 
measured instead of dots. 
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Post rranslational modification of the recombinant protein 
Recombinant proteins were cleaved widi endopepridase F/N-glycosidase nuxture 
(Boehringer Mannheim Biochemicals. Indianapolis, IN) and endopepridase H 
(Boehringer Mannheim Biochemicals, Indianapolis, IN) to determine glycosylation of the 
proteins expressed in the baculovirus system. The insect cells infected with recombinant 
baculoviais were labeled at 72 hours with ^^S-methionine/cysteine (ICN Biochem.. 
Costa Mesa, CA) for 2 hours post infection. Cell lysates were then prepared as 
described under the radioimmunoprecipitation procedure. Metabolically labeled 
recombinant proteins were separated from protein-A-anribody complex by boiling, using 
an elution buffer (50 mM Tris/Cl, 0.5 % SDS, and 0.1 M p-mercaptoethanol, pH 6.8), 
followed by centrifugation. The eluted proteins were treated with 250 mU of 
endopepridase F/N-glycosidase F mixture (5 fil 40 mM sodium phosphate, pH 7.2.4% 
(v/v) NP40, 20 mM EDTA buffer. 20 |ig PMSF, and 10 |J.l sample) and 5 mU of 
endopepridase H (5 [il 200 mM sodium citrate, pH 5.5 buffer. 20 |ig PMSF, and 10 |il 
9 
sample) in separate tubes overnight at 37 C. Endopepridase-treated samples were boiled 
for 5 minutes and separated on SDS-PAGE and X-ray film (Fuji RX fihn. Japan) was 
exposed to the dried gels. 
Results 
Molecular Cloning and analysis ofVPJgene 
The VP7 gene of the bovine rotavirus VMRi strain was cloned in the pKS"^ 
plasmid vector and inserts in three recombinant clones were sequenced. The complete 
sequence of VP7 of VMRI strain is presented elsewhere (Mummidi et al, manuscript 
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submitted for publication). Terminal sequence and location of four primers P1-P4 are 
shown in Fig. I. There was one large open reading frame with the start position at 49 
and termination at 1026 (Fig. 1). All of the modifications of VP7 for expression were 
carried out using primers based on the sequence information as depicted in Fig 1. 
Generation of Recombinant Baciilovinis 
To optimize expression of the recombinant VP7 protein, four constructs of the 
VP7 gene of bovine rotavirus strain VMRJ were generated using primers PI. P2. P3 and 
P4 (Fig. 1) by PGR as depicted in Fig. 2. The PGR product VP7.A contained the full 
VP7 gene sequence with BamHI and EcoRI restriction sites and was 1083 base pairs in 
length. The PGR product VP7.B was 983 base pairs in length in which noncoding 
sequence downstream of the stop codon of VP? was removed. The PGR product VP7.G 
was 1038 base pairs in length, was missing non-coding sequence upstream of the VP7 
start codon but contained an additional TAAATA sequence. The founh PGR product 
VP7.D was 941 bases long and was missing the non-coding region upstream and 
downstream of VP7 open reading frame. These PGR amplified DNAs were cloned into a 
baculovirus transfer vector pVLI393 (Invitrogen, San Diego, GA). Three clones of each 
construct were selected and DNAs purified and quantitated. The pure DNAs from 
recombinant plasmids were isolated and used for transfection of Hi-Five insect cells 
along with baculovirus DNA. Occlusion negative plaques containing inserts were 
picked, purified, and the presence of recombinant virus confirmed by dot-blot 
hybridization. Stocks of recombinant baculovirus were then prepared. Progeny of 
occlusion-negative plaques were positive by dot blot hybridization for the presence of 
rotavirus VP7 gene (Fig. 3). Fig. 4 shows the cytopathic effect induced by progeny of 
occlusion negative recombinant virus and occlusion positive wild t>'pe baculovirus. The 
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GGCTTTAAAAGAGAGAATnCCQTryGGCVKGCGGTYkGC 40 
PI 
TCCTTTTA4rGr/\rGGrA7TCAATATACCACAATTCTAAT 80 
P2 
A Tr.r.TGGrAAr.TGTTCTACACAGTGGTGGATTAGCTrA/^r 960 
P3 
CM47MTTCA AACG ATGTCCAAAAGGTCTAG ATC ACTTA 1000 
ATTCGTCAGCGTTCTATTACAGAGTATAGGTGCATGTTAG 1040 
kTTKGGATTAGTATGATGTGACC 1063 
P4 
Fig I. Partial nucleotide sequence of VMRIVP7 gene at termini showing positions of 4 
primers PI, P2, P3 and P4 used for PGR for elimination of noncoding regions upstream 
and downstream of the VP7 OEIF. Bold characters indicate start or stop codon, and italics 
are primer sequences without oligonucleotide for restriction endonuclease recognition 
sites. 
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MCS 
pVL1393 
VP7.A 
VP7.B 
VP7.C 
VP7.D 
MCS 
ATG TAG 
ATG TGA 
.^TG TAG 
ATG TGA 
PGR Amplified VP7 gene 
pVL/VP7 A, B, C, and D 
Fig 2. Construction of VMRI VP7 genes in baculovirus transfer vector pVL1393 and 
short arrow inside circle indicate direction of translation. (MCS: Multi cloning site, PH: 
polyhedrin promoter). Recombinant baculovirus transfer vector with fuU VP7 gene 
(pVL/VI^.A) deletion in 3'-end (pVLAT7.B), deletion in 5'-end (pVLA'P7.C) and 
deletion in both 5' and 3' ends were constructed. Abbreviations: MCS= multiple cloning 
site, PH= polyhedrin promoter. 
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VP7 gene probe hybridized with nucleic acids isolated from insect cells infected with 
recombinant baculovirus but not with nucleic acid from wild type baculovirus (Fig. 3). 
Similarly, baculovirus transfer vector pVL1393 DNA were applied on the same 
hybridization reaction but no signal was detected. 
Qiiantitctton of mRNA 
Relative concentration of VP7-specific mRNA transcribed in cells infected with 
four recombinant baculovinises was determined by dot blot hybridizarion. Total mRNA 
from insect cells was hybridized with the VP7 gene probe prepared from VMRl strain of 
rotavirus and signals were compared by image analysis for relative concentration. 
Messenger RNA was detected in cultures infected with any of the four recombinant 
baculovinises (Fig. 6). In contrast, VF7 mRNA was not detected in uninfected cells or 
cells infected with the wild type baculovirus (Fig. 4). Level of mRNA with recombinant 
baculovirus Bac.pVLA^.A, Bac.pVLAHPV.B, and Bac.pVLA^7.C was similar (Table 
1). In contrast, the level of mRNA with recombinant baculovirus Bac.pVL/'VP7.D was 
over two times more than that detected in Bac-pVLATT-A, Bac.pVLATT.B, or 
Bac.pVLA^T.C. This result indicated that removal of both the 5' and 3' non-
translational sequences increases transcription of VP7 of bovine rotavirus in the insect 
cell system. 
Qiianntaiion and partial characterization of recombinant proteins 
To test the authenticity of expressed VP7 protein, reactivity of recombinant 
protein with polyclonal anri-rotavirus serum in the indirect immunofluorscence and 
radioimmunoprecipitation tests was determined. Antiserum to the VMRI strain of bovine 
Fig. 3. Identification of VIvIRJ VF7 gene insert in recombinant baculovirus by dot blot 
hybridization using -'^p-iabeled PCR-derived VMRIVP7 gene probe. Nucleic acid was 
extracted from partially purified recombinant viruses and DNA concentration measured by 
spectrophotometer. Nucleic acid from recombinant baculovirus Bac.pVLA^.A (A), 
Bac.pVLAT^.B (B), Bac.pVLA''P7.C (C), Bac.pVLA'PT.D (D), wild type baculovirus 
(W), and Hi-Five insect cells (H) was applied on nylon membrane using 96-well manifold 
and hybridized with VMRI VP7 gene probe. 
H 
W 
Fig. 4. Cytopathic effect of recombinant baculovirus Bac.pVLAT7-A (A), 
Bac.pVLAT^.B (B), Bac.pVLA'PT.C (C) or Bac.pVLA'T^.D (D) and occlusion positive 
wild type baculovirus in insect cells (W). CPE was photographed at 72 hour post 
infection. 
A C 
D H W 
Fia. 5. Stainins of insect cells infected with recombinant viruses Bac.pVLATT.A (A), 
Bac.pVLA^P7.B (B), Bac.pVL/VP7.C (C), and Bac.pVL/VP7.D (D) by indirect 
immunofluorescence with guinea pig antiserum to VMRI strain of bovine rotavirus. MA-
104 cells infected with VMRI strain of bovine rotavirus were used as control (V). 
A B C  
D V H 
148 
rotavirus reacted with cells infected with recombinant baculovirus containing the VMRI 
VP7 gene (Fig. 5). Immunofluorescence was cytoplasmic and specific to rotavirus. 
Immunofluorescence was not detected in uninfected cells and cells infected with the wild-
type baculovirus. For radioimmunoprecipitation. insect cells were infected with 
recombinant baculoviruses Bac.pVLAT^.A, Bac.pVLATT.B, Bac.pVLA'^PT.C, 
Bac.pVLAT^ D or wild-type baculovirus and cell lysates from these were 
immunoprecipitated with and-VMRI rotavirus serum and analyzed by SDS-PAGE (Fig. 
7). A protein band was observed in cells infected with any of the four recombinant 
baculoviruses containing VP? gene insert. Protein of similar size was not detected in 
uninfected cells or cells infected with the wild type baculovirus. The molecular mass of 
the recombinant protein was approximately 37.3 IcDa which is similar to the 38 kDa 
reponed for rotavirus (Fig. 8). The protein band was diffuse which suggested that the 
protein was glycosylated. Recombinant baculovirus Bac.pVLAT7.D, which had both 5' 
and 3' deletion, had thickest precipitation band suggesting that the recombinant protein 
expression in this construct was more abundant than that in the others. Expression of 
recombinant proteins in cells infected with recombinant baculovirus containing VP7 gene 
was compared by image analysis of RIP bands. The VP7 expression in cells infected 
with the recombinant baculovirus Bac.pVLA'P7.D was approximately 10 fold more than 
that in cells infected with recombinant baculovirus Bac.pVLA^.B or Bac.pVLAT'7.C 
and about 40 times more than that in cells infected with Bac.p VLA'P7.A (Table 2). 
To determine whether VP7 protein expressed in insect cells was glycosylated, 
proteins were radiolabeled, treated with endopeptidases to cleave the glycosylated side 
chains and analyzed. Endopeptidase F/N-glycosidase F mLxture and endopeptidase H 
o 
effectively cleaved recombinant protein VP7 after overnight incubation at 37 C. Cleaved 
products migrated faster than that for uncleaved protein (Fig. 9). This result indicated 
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Table I. Comparison of mRNA levels in insect cells infected with wild type or 
recombinant baculoviruses. 
Geometric mean concentration of VP7 mRNA 
Baculovirus* as a density of hybridization signal + S.D** 
Bac.pVL/VP7.A 
Bac.pVLAT7.B 
Bac.pVLATT.C 
Bac.pVLA^V.D 
AcMNPV 
2,720.54 ± 149.5 
2,763.63 ± 18.67 
2,680.00 ± 160.87 
5,526.22 ± 93.94 
424.71 + 24.09 
*AcMNPV= wild type baculovirus; Bac.pVLA'P7.A= recombinant baculovirus with full 
VP7 gene; Bac.pVLAT7.B= VP7 gene with deletion in 3'-end; Bac.pVLA'P7.C= VP7 
gene with deletion in 5'-end; Bac.pVLAT'7.D= VP7 gene with deletion in 5' and 3' 
ends. 
** Geometric mean values with standard deviation of dot hybridization signals generated 
by image analysis. Total mRNA from cells iiifected with virus were hybridized with 
rotavirus VP7 gene. Signal in dot quantitated by image analysis. The data was analyzed 
statistically using Friedman rank sums test and Bac.pVLA'P7.D showed significant 
increase to other constructs (P<0.042). There is no significant difference among 
recombinant transfer vector constructs Bac.pVLA''P7. A, Bac.pVLAT7-B and 
Bac.pVLA^7.C. 
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Table 2. Comparison of VP7 expressed in cells infected with recombinant bacuiovirus 
containing VP7 insert of varying length. 
*AcMNPV= wild type: Bac.pVL/VP7.A= recombinant bacuiovirus with full VP7 gene; 
Bac.pVL/VP7.B= gene with deletion in 3'-end; Bac.pVLAT^.C= VP7 gene with 
deletion in 5'-end; Bac.pVLA'^P7.D= VP7 gene with deletion in 5' and 3' ends. 
Rotavirus specific VP7 protein band following immunoprecipitation of cell lysates with 
wild type or recombinant bacuiovirus were quantitated by image analysis. 
** Geometric mean values with standard deviation of radioimmunoprecipitation band 
signals generated by image analysis. The data was analyzed statistically using Friedman 
rank sums test and Bac.pVLA'P7.D showed sisnificant increase to other constructs 
(P<0.004). 
Bacuiovirus* 
Geometric mean relative concentration of VP7 as a 
density of radioimmunoprecipitation band ± ** 
Bac.pVL/VP7.A 
Bac.pVLA^7.B 
Bac.pVLA'P7.C 
Bac.pVLAT7.D 
AcMNPV 
595.50 ± 36.23 
1,842.51 ± 174.68 
1.908.92 ±209.92 
20,786.23 ± 1045.3 
0.0 
Fig. 6. Dot blot hybridization of total mRNA isolated from insect cells infected with 
recombinant baculovinis Bac.pVL/VP7.A (A), Bac.pVLAT7.B (B), Buc.pVLA'^Py.C (C), 
Bac.pVL/yP7.D (D) or wild type baculovirus AcMNPV (W) with ^-P-labeled VMRI VP7 
gene specific probe. 
m 
m 
Fig. 7. Radioimmunoprecipitation of recombinant baculovirus Bac.pVLA'^P7.A, 
Bac.pVL/VP7.B, Bac.pVLAT^.C, and Bac.pVL/VP7.D and their relative concentrations 
by image analysis. 
B C 
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Fig. 8. Radioimmunoprecipitation of recombinant protein expressed in insect cells infected 
with recombinant baculovirus Bac-pVLATT-D. Proteins were labeled with 35s-met/cys 
and immunoprecipitated with and-VMRI serum. Molecular mass of recombinant protein 
was 37.3 kDa. 

Fig. 9. Radioimmunoprecipitation of recombinant VP7 protein with anti-VMRI rotavirus 
senim following endopeptidase treatment The protein was treated with Endo-H (lane H) 
or Endo-F (lane"Endopeptidase treated VP7 migrated faster than untreated VF7 
indicating that recombinant VP7 protein is glycosylated. The Mr of untreated VP7 (closed 
triangle) was 37.3 kDa. 
U F H 
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that the recombinant protein VP7 expressed in baculovirus was effectively glycosylated 
and side chains could be removed by treatment with endopepridases. 
Discussion 
A number of different prokaryotic and eukaryoric vectors have been used to 
express viral proteins. Eukaryoric vectors have an advantage over prokaryodc vectors in 
post-translational modification such as protein folding which appears to be imponant in 
immunogenicity of certain recombinant proteins (Francavilla et al. 1987; Redmond. 
1993). The helper independent baculovirus is one of the most popular eukaryotic 
expression systems for expression of viral proteins for their characterization and use as 
diagnostics and vaccines. In this expression system, foreign genes are expressed under 
the transcriptional control of the very strong and late baculovirus polyhedrin gene 
promoter (Summers and Smith. 1989: O'Reilly et ai. 1992). The baculovirus system has 
been used to express many viral, mammalian, plant and prokaryotic genes in an abundant 
amount and in a functionally authentic form (Kang, 1988; Smidi et al. 1983; Luckow et 
al. 1988a. 1989; Davis et al. 1992). Expression levels of recombinant proteins do vary 
in this expression system. Factors that influence protein expression levels in baculovirus 
are not completely understood. Some of the factors that are believed to influence the 
expression levels include the insect cell line, gene expressed, distance between 
polyhedrin promoter, and start site of foreign gene. Insect cell lines TNI-TN-5B1-4 (Hi-
Five) and BTI TnM have been reponed to be superior to Sf21 and Sf9 in protein 
expression (Wickham et al. 1992). In a preliminary experiment, we also compared 
expression of bovine rotavirus VP6 in Sf9 and Hi-Five cells. The expressed protein 
levels in Hi-Five cells was much greater than that in Sf9 cells. Therefore, in this 
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experiment we used Hi-Five cells grown in insect cell culture medium Excell 400 without 
serum supplement for maximum expression. Other factors that are expected to contribute 
to the recombinant protein expression are the properties of a given gene, RNA stability, 
and protein processing, transport targeting and stability. But these have not been studied 
in detail (Luckow et al. 1988). To optimize gene expression in the baculovirus system, it 
has been recommended that genes be used without introns. Removal of 5' noncoding 
sequences longer than 30 bp, removal of 3' untranslated sequence which may destabilize 
mRNA and addition of TAAG which may specify transcriptional initiation in an 
eukaryotic system is also recommended for optimal gene expression (O'Reilly et al. 
1992). Sequences proximal to the polyhedrin promoter can also have a dramatic 
influence on the level of expression in the insect cell system (Luckow et al. 1988a; Kang 
etal. 1988). 
Several reovirus and rotavirus proteins including VP7 have been successfully 
expressed and characterized using baculovirus as an expression system (Nishikawa, 
1989; Labbe, 1991; Loudon, 1991). These recombinant proteins were evaluated as 
potential vaccines in experimental animals to prevent rotavirus gastroenteritis (Redmond 
et al. 1993; Bishop, 1993). Bovine rotavirus C486 VP7 recombinant protein was 
expressed in insect cells using a pAcYMl as a transfer vector. In this report seven 
nucleotides from the 5' end and 27 nucleotides from the 3' end were removed by 
restriction enzj/me digestion of the cloned cDNA (Sahara et al. 1989). Expression of 
rotavirus proteins in insect cells peaked at 48 hours after infection, and low yields of VP? 
protein expression was attributed to the secTetion of the protein into the culture medium 
(Redmond et al. 1993). The VP7 protein expression peaked at 24 hours post infection in 
Sf9 cells and 96 hours post infection in the supernatant of the recombinant virus infected 
insect cells. In this experiment, recombinant protein VP7 expression peaked at 72 hours 
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post infection in Pli-Five cells and recombinant protein was released into the culture 
medium after extensive cytopathic effect (data not shown). Simultaneous expression of 
VP6 and VP7 formed double-shelled like particles in insect cells which indicates that VP6 
is required for the virus-like particle formation (Sahara et al. 1991). 
In this study, expression using the full VF7 gene was poor. Therefore, we 
examined the effect of deleting non-coding regions upstream and downstream of the VP7 
gene ORF in its expression. Removal of either the 5' or 3' non-coding region increased 
protein expression two fold over that with the full gene. Removal of both the 5' and 3' 
end had a major impact on the level of mRNA transcription and protein expression. 
Removal of the 5' non- translated DNA sequences allowed the VP7 gene location close to 
the polyhedrin promoter as well as eliminated the sequence with high GC content 
upstream of the VF7 gene start codon. Deletion of the 3' end allows elimination of AT 
rich sequences which possibly destabilize mRNA transcript Also the sequence added 
upstream of ATG might increase transcriptional initiation activity. After these alterations 
of the VP7 gene we expected more mRNA transcription and protein expression than 
when using the full length VP7 gene. Messenger RNA transcription was highest in 
Bac.pVLA^P7.D which has deletions both at 5' and 3' ends. Deletion of both the 5' and 
3" non-translational sequences increased expression of recombinant protein but undeleted 
or a single deletion at 5' or 3' end deletion did not alter expression of VP7 proteins in this 
insect cell system. We conclude that deletion of noncoding sequences at both the 5' and 
3' ends of bovine rotavirus VP7 gene was an important requirement for optimal 
expression of the VP7 protein in insect cells. Based on all data obtained from this 
experiment, we could improve recombinant protein expression in baculovirus system by 
deletion of non-coding sequences. 
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GENERAL CONCLUSIONS 
The first paper describes expression and characterization of bovine rotavirus 
proteins in the baculovirus system. Bovine rotavirus VP2. VP4, VP6 and VF7 of the 
VMRI strain were cloned in phagemid vector pKS"*" and the size of these clones were 
found to be 2.67, 2.36, 1.36 and 1.06 kb for VP2. VP4. VP6 and VP7. respectively. 
These sizes were comparable to that of the corresponding genes of other bovine 
rotavirus. Sequencing data of these cloned genes were used for designing primers for 
PCR amplification and insertion of these genes into the baculovirus transfer vectors. 
We then expressed recombinant rotavirus proteins VP2, VP4, VP6 and VP7 
using baculovirus vectors. Bovine rotavirus specific antigens were detected from cells 
infected with recombinant baculoviruses by indirect immunofluorescence using 
hyperimmune serum to the VMRI strain of BRV. All of the recombinant proteins 
expressed in insect cells showed widespread cytoplasmic fluorescence by DFA. The 
molecular mass of these recombinant proteins was measured by 
radioimmunoprecipitation using hyperimmune serum to the VMRI strain of BRV. 
Antigenicity of these recombinant proteins were evaluated in guinea pigs. 
There was no significant difference in the titers of the different recombinant 
baculoviruses Bac.pBA^2. Bac.pVLA^P4, Bac.pVLA^6 and Bac.pVLA'^PV. But 
recombinant virus titers in insect cells were much higher than the titers of the VMRI 
strain of BRV grown in MA-104 cells. The titer of the VMRI strain grown in MA-104 
cell culture was IG^-O PFU/ml by an indirect immunofluorescent test using hyperimmune 
serum to the VMRI strain of BRV, raised in guinea pigs. Recombinant virus titers 
determined by an indirect immunofluorescent test using the same antiserum in insect cells 
were 10^-^ FFU/ml for recombinant baculovirus Bac.pB/VP2, lO^-O FFU/ml for 
170 
Bac.pVLA^4, 108.5 PFU/ml for Bac.pVL/VP6 and lO^-O FFU/ml for Bac.pVL/VP7, 
respectively. The titers of the reconribinant baculoviruses were comparable to that of the 
wild type baculovirus AcMNPV, in the same insect cell system. 
Molecular mass of the recombinant proteins expressed in insect cells were 
identified by radioimmunoprecipitadon. The molecular mass of recombinant protein VP2 
expressed in insect cells was approximately 102 kDa which is similar to that of the VP2 
protein in BRV. Another slower migrating protein was also detected in the cells infected 
with recombinant baculovirus Bac.pBA^P2. This band possibly represent a heavy 
glycosyladon product which is common in the baculovirus expressed proteins. Three 
cleavage products, VP5, VP8, and VP8a were detected in cells expressing recombinant 
protein VP4. The VPS product has been shown to possess hemagglutinin activity with 
an approximate molecular mass of 28 kDa (Fiore et al., 1991). The VP5 is about a 60 
icDa protein which is on the carboxy terminal side of the VP4 protein (Mattion et al., 
1994). In this study, we also observed a faster migrating protein VP8a which is believed 
to be due to the cleavage VP4 at amino acid residue 231. In this expression system, the 
majority of the VP4 recombinant protein expressed in the insect cell system was intacL 
This abundant amount of expressed VP4 might be an advantage in the immunization of 
animals. It was reported that in the RJP of a rotavirus grown in mammalian cells, the 
VP4 protein was very faint and the VPS and the VP8 proteins were almost undetectable 
(Estes. 1990). In this study, the baculovirus expressed recombinant protein VP4 clearly 
showed an advantage in protein expression over the mairunalian cell culture system. 
Using a recombinant protein expression in insect cells, we have successfully 
demonstrated that the arginine at amino acid residue 231 of the VP4 protein is an active 
cleavage site for cellular proteolytic enzymes, and insect cells have the ability to process 
recombinant rotavirus protein in the same manner as meunmalian cells. An additional 
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putative proteolytic enzyme cleavage site at amino acid residue 231 found in the VP4 
gene sequence was confirmed as a proteoljmc enzyme cleavage site. During expression 
of the recombinant protein we observed that VP6 was most abundandy expressed in 
insect cells by IFA and coomassie staining of the protein by SDS-PAGE (data not 
shown). We do not understand the mechanisms for higher expression of recombinant 
protein VP6, over the other rotavirus proteins in the insect cells system. Since the VP6 
protein is the most abundant viral protein in the rotavirus virion which is composed of 
over 60% of the viral proteins, we speculate that the VP6 gene has some inherent 
property that affects its expression. Deletions of noncoding sequences at the 5' and 3' 
ends of the VP7 gene increased recombinant protein expression. A diffuse band in the 
VP7 RIP indicates diat the protein expressed in baculovirus is post translationally 
modified and shows an advantage of an eukaryotic expression system over a prokaryotic 
expression. Since proteins expressed in baculovirus had a similar molecular mass to that 
of rotavirus and glycosylarion of VP7, we expect that biological acriviries of recombinant 
proteins to be similar to those of rotavirus. 
We determined the kinetics of recombinant rotavirus protein expression in 
insect cells by radioimmunopredpitation. The highest expression of VP6 was at 72 hour 
post infection. Recombinant proteins were not secreted into the culture medium from any 
of the recombinant viruses during the early stages of infection. We were able to detect 
recombinant proteins in the medium during the late stages of infection but it was due to 
the extensive cytopathic effect of recombinant virus uifected insect cells rather than 
protein secretion. This is not unusual for proteins expressed in an insect cell system to 
show a lack of protein secretion in the medium (Wickham et al, 1992). 
Two different types of CPE were observed in recombinant virus infected insect 
cells. One type was cell rounding followed by lysis and the other was fusion of the 
172 
insect cells followed by lysis. Based on the CPE in the recon:ibinant virus infected cells 
VP4 and VP7 showed cell fusion activides. Especially, insect cells infected with 
recombinant baculovirus expressing VP4 fused together significantly, indicating that 
recombinant protein VP4 expressed in insect cells possess fusion activity that is similar to 
that of the native viral protein VP4. The recombinant virus VP7 also showed weak 
fusion activity in insect cells which was unexpected. This activity may indicate that VP7 
is a putative cell receptor binding protein in mammalian cells. 
Current research results indicate that baculovirus expressed viral proteins self 
assemble into virus-like particles and these are immunogenic in experimental animals 
(French and Roy, 1990: Luo et al., 1990; Sahara et al., 1991; Loudon and Roy, 1991: 
Jiang et al.. 1992; Laurent et al.. 1994; Prasad et al., 1994). This data may suggest that 
the baculovirus expression system has an advantage over other expression systems such 
as E. coli. In this experiment we have successfully produced virus-like particles by 
using combinations of recombinant viruses expressing rotavirus proteins. Infection of 
insect cells with Bac.pBAT'2 produced sub-core particles and the size of these particles 
was similar to that of BRV subcores. The sub-core particles expressed in insect cells 
were similar to that of previous reports (Labbe et al., 1991; Zeng et al., 1994). Co-
infection of insect cells with recombinant viruses Bac.pB/VP2. Bac.pVLAT'4. 
Bac.pVLAT6, and Bac.pVL/VP7 produced rotavirus like particles in insect cells without 
core structures containing nucleic acid and proteins VP I and VP3. 
Morphology and size of the recombinant empty particles was 70-75 nm in 
diameter which similar to that of rotavirus particles purified from tissue culture grown 
VMRl strain of BRV. Crawford et al., (1994) had similar result with rotavirus capsid 
proteins expressed in insect cells. Also there were mbular strucmres in insect cells 
infected with recombinant baculovirus. This indicates that the empty virus particles bud 
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out from primary tubular structures. The results of our data suggests that VP2 and VP6 
are required for VLP formation. 
Evaluation of antigenicity of recombinant proteins in guinea pigs showed that 
VP2. VP4, \T6 and VP7 are antigenic, however only VP4, VP6 and VP7 possess 
ability to induce neutralizing antibodies. The VP4 and VP7 appear to be major 
immunogen as reported previously (Paul and Lyoo. 1993) Ability of VP6 to produce 
low level of neutralizing antibodies was surprising and needs further investigation 
especially in the light of findings of Redmond et al. (1993) that VP6 can provide partial 
immunity to rotavirus associated gastroenteritis. 
There has been a controversy as to which rotavirus protein is responsible for 
binding to culture cells. Both VP4 and an outer capsid glycoprotein have been proposed 
to play a role in binding to receptors on rotavirus susceptible cells (Sahara et al., 1985: 
Ruggeri and Greenberg, 1991). In another study (Bass et al., 1990) a nonstructural 
rotavirus protein suggested as the major protein responsible for binding to target cells 
(Bass et al., 1990). Because of the controversy surrounding the role of different proteins 
in binding with the receptor, we examined the role of recombinant VP4 and VP? in cells. 
Our results indicate that VP4 and VP7 proteins are important for the cell binding. In this 
study, we have clearly shown that both VP4 and VP7 are the major proteins responsible 
for binding to MA-104 cells. Baculovirus expressed recombinant rotavirus proteins VP4 
and VP7 independentiy blocked target binding of the VTvIRI strain of BRV to MA-104 
cells, resulting in no virus infection in the cells. The virus neutralization test results also 
support this hypothesis (Table 16). Resistance of receptor binding activity to trypsin 
treatment as observed by Kaljot et al. (1988) further supported our results that VP4 and 
VP7 are the major proteins responsible for virus binding to cells. The number of 
rotavirus receptors on MA-104 cells was shown to be lO^-lO^-^ receptors per cells for 
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the VMRI strain of BRV. This estimate is lower than that of lO^-O/cell reported by 
Kaljot (1990). This difference in results may be due to the different passage level of 
susceptible cells and/or the different strain and passage levels of rotavirus. 
The second paper describes that recombinant protein VP? expression is increased 
by modification of sequences upstream and downstream of the ORF. In a preliminary 
experiment, we also compared expression of bovine rotavirus VP6 in Sf9 and Hi-Five 
cells. The expressed protein levels in Hi-Five cells was much greater than that in Sf9 
cells (data not shown). Therefore, in this experiment we used Hi-Five cells grown in 
insect cell culture medium Excell 400 without serum supplement for maximum 
expression. Other factors that are expected to contribute to the recombinant protein 
expression are the properties of a given gene, RNA stability, and protein processing, 
transport targeting and stability. But these have not been studied in detail (Luckow et al.. 
1988). To optimize gene expression in the baculovirus system, it has been recommended 
that genes be used without introns. Removal of the 5' noncoding sequences, if longer 
than 30 bp, 3' untranslated sequence which may destabilize mRNA and the presence of 
TAAG which may specify transcriptional initiation in an eukaryotic system are also 
recommended for optimal gene expression (O'Reilly et al., 1992). Sequences proximal 
to the polyhedrin promoter can also have a dramatic influence on the level of protein 
expression in the insect cell system (Luckow et al., 1988a: Kang et al., 1988). 
Several reovirus and rotavirus proteins including VP7 have been successfully 
expressed and characterized using baculovirus as an expression system (Nishikawa, 
1989; Labbe, 1991; Loudon, 1991). These recombinant proteins were evaluated as 
potential vaccines in experimental animals to prevent rotavirus gastroenteritis (Redmond 
etal. 1993; Bishop, 1993). Bovine rotavirus C486 VP7 recombinant protein was 
expressed in insect cells using pAcYMl as a transfer vector. In this repon, 7 bp from the 
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5' end and 27 bp from the 3' end were removed by restriction enzyme digestion of the 
cloned cDNA (Sahara et al. 1989). Expression of rotavirus proteins in insect cells 
peaked at 48 hours after infection, and low yields of VP7 protein expression was 
attributed to the secretion of the protein into the culture medium (Redmond et al. 1993). 
The VP7 protein expression peaked at 24 hours post infection in Sf9 cells and 96 hours 
post infection in the supernatant of the recombinant virus infected insect cells. In this 
experiment, recombinant protein VP7 peaked at 72 hours post infection in Hi-Five cells 
and recombinant protein was released into the culture medium after extensive cytopathic 
effect (data not shown). Simultaneous expression of VP6 and VP7 formed double-
shelled like particles in insect cells which indicates that VP6 is required for the virus-like 
particle formation (Sabara et al., 1991). 
In this study, expression using the full VP7 gene was poor. Therefore, we 
examined the effect of deleting non-coding regions upstream and downstream of the VP7 
gene ORF on its expression. Removal of either the 5' or 3' non-coding region increased 
protein expression two fold over that with the fuU gene. Removal of both the 5' and 3' 
end had a major impact on the level of mRNA transcription and protein expression. 
Removal of the 5' non- translated DNA sequences allowed the VP7 gene location close to 
the polyhedrin promoter, as well as eliminated the sequence with high GC content 
upstream of the VP7 gene start codon. Deletion of the 3' end allowed elimination of AT 
rich sequences which possibly destabilize mRNA transcript Also the sequence added 
upstream of ATG might increase transcriptional initiation activity. After these alterations 
of the VP7 gene we expected more mRNA transcription and protein expression than 
when using the full length VP7 gene. Messenger RNA transcription was highest in 
Bac.pVLAT^.D which has deletions at both 5' and 3' ends. Deletion of non-
translational sequences both at the 5' and 3' increased expression of recombinant protein 
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but no deletion or a single deletion at the 5' or 3' end did not alter expression of VP7 
proteins in this insect cell system. We conclude that deletion of noncoding sequences at 
both the 5' and 3' ends of the bovine rotavirus VP7 gene was an important requirement 
for increased expression of the VP7 protein in insect cells. 
Rotaviruses of G type 6 and P type I are most prevalent in calves with 
gastroenteritis (Hardy et al., 1992). This simplicity may allow a feasible approach in 
developing an effective vaccine which can be beneficial to the cattle industry in the 
prevention of rotavirus associated gastroenteritis in calves. Even though the serological 
diversity of bovine rotavirus is Limited, prevention of rotavirus infection in calves has 
proven to be a difficult problem and remains to be solved. We believe the recombinant 
proteins VP4 and VP7 offer a valuable tool for development of an effective vaccine for 
the prevention and control of rotavirus associated gastroenteritis. 
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